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ABSTRACT
Genotyping, antibiotic resistance and biofilm formation of
Stenotrophomonas maltophilia clinical isolates from Serbia
Stenotrophomonas maltophilia is an environmental bacterium and an
opportunistic pathogen usually associated with healthcare-associated
infections, which has recently been recognized as a global multidrug resistant
organism. The aim of this study was genotyping and physiological
characterization of S. maltophilia collected during the routine health care at The
Institute for Mother and Child Health Care of Serbia “Dr Vukan Čupić“. It is the
large, tertiary care pediatric hospital in Belgrade, Serbia, hosting the national
reference cystic fibrosis (CF) center for pediatric and adult patients.
We characterized 88 S. maltophilia strains, 42 strains of cystic fibrosis (CF)
and 46 strains of non-cystic fibrosis (non-CF) origin isolated from 2013 to 2015
in order to investigate their genetic relatedness and phenotypic traits.
Genotyping was performed using sequencing of 16S rRNA gene, Pulse Field
Gel Electrophoresis (PFGE) and Multi locus sequencing typing (MLST) analysis.
Sensitivity to five relevant antimicrobial agents was determined, namely
trimethoprim/sulfamethoxazole (TMP/SMX), chloramphenicol, ciprofloxacin,
levofloxacin and tetracycline. Surface characteristics, motility, biofilm formation
and adhesion to mucin were tested in all strains. In addition, influence of
different factors (temperature, pH, agitation and CO2) on biofilm formation,
kinetics of selected biofilm producers and effect of TMP/SMX on formed
biofilm were analyzed. Statistical approach was used to determine correlations
between obtained results.
All analyzed clinical isolates belong to S. maltophilia species with identity
ranging from 95% to 99% with S. maltophilia strains from the NCBI database
what was confirmed by sequencing of PCR products of amplified 16S rRNA
gene. PFGE analysis confirmed that most of the isolates were not genetically
related. Six new sequence types were determined and three already detected
were found. Strains were uniformly sensitive to all tested antimicrobial agents.
Swimming motility was observed in all strains, while none of the them
exhibited swarming or twitching motility. Among strains able to adhere to
mucin, no differences between CF and non-CF isolates were observed.
The majority of isolates (89.8%) were able to form biofilm with almost
equal representation in both CF and non-CF strains. Analysis of biofilm
formation in different growth conditions showed that changing of temperature
and pH had the strongest effect on biofilm formation almost equally in group of
cystic fibrosis (CF) and non-CF strains. TMP/SMX in concentration of 50 µg/ml
reduced completely 24 h old biofilms while concentration of 25 µg/ml effects
formed biofilms in a strain dependent manner. Among strains able to form
strong biofilm CF isolates formed biofilm slower than non-CF isolates.
Agitation conditions did not affect biofilm formation.
High genetic diversity among isolates implies the absence of clonal
spread within the hospital. Positive correlation between motility, biofilm
formation and adhesion to mucin was demonstrated. In addition, positive
correlation between motility and strength of biofilm formed was demonstrated.
Biofilm formation and motility were more pronounced among non-CF than CF
isolates. However, a comparison of phenotypic characteristics of clinical isolates
from CF and non-CF patients suggested that there was a difference between the
two populations but not a CF phenotype.
Keywords: Stenotrophomonas maltophilia, healthcare-associated infections,
trimethoprim–sulfamethoxazole, biofilm, PFGE, MLST
Scientific field:Molecular biology
Specific scientific field: Molecular microbiology
UDC: [579.253:[579.841:[574.58+616-78]]:[579.61:616-092](497.11)(043.3)
РЕЗИМЕ
Генотипизација, резистенција на антибиотике
и формирање биофилма клиничких изолата
Stenotrophomonas maltophilia из Србије
Stenotrophomonas maltophilia је срединска бактерија и опортунистички
патоген који се најчешће повезује са нозокомијалним инфекцијама, а од
скоро је сврстан у групу глобалних патогена који су вишеструко
резистентни на антибиотике. Циљ ове докторске дисертације јесте
гнеотипизација и фенотипска карактеризација колекције S. maltophilia која
је сакупљена током свакодневне здравствене неге пацијената у Институт за
здравствену заштиту мајке и детета „др Вукан Чупић“. То је велика
педијатријска болница у оквиру које се налази национални центар за
лечење деце и одраслих оболелих од цистичне фиброзе.
У раду је окарактерисано 88 сојева S. maltophilia од којих 42 пореклом
из пацијената оболелих од цистичне фиброзе (ЦФ) и 46 из пацијената који
су имали друга оболења (нЦФ). Сојеви су скупљени у периоду од 2013. до
2015. године у циљу изучавања генетичке сродности и фенотипских
особина. Секвенцирање PCR производа добијеног умножавањем гена за
16S рРНК, електофореза у пулсирајућем пољу (PFGE) и типизација
секвенцирањем више локуса (MLST) су методе које су коришћене за
генотипизацију. Анализирана је осетљивост на одабране релевантне
антибиотике и то, триметоприм-сулфаметаксазол (ТМП/СМX),
хлорамфеникол, ципрофлоксацин, левофлоксацин и тетрациклин. Код
свих сојева су анализиране површинске карактеристике, покретљивост,
способност формирања биофилма и адхезије на муцин. Такође,
анализиран је и утицај различитих фактора (температура, pH, шејкирање
и CO2) на формирање биофилма, кинетика формирања биофилма код
одабраних сојева као и утицај ТМП/СМX на формирани биофилм.
Добијени резултати су статистички обрађени у циљу утврђивања
корелација међу њима.
Секвенцирање PCR производа добијених умножавањем гена за 16S
рРНК добијено је да сви анализирани клинички изолати припадају врсти
S. maltophilia са идентичношћу од 95% до 99% са S. maltophilia из NCBI базе
података. PFGE анализом је потврђено да међу изолатима постоји велика
генетичка хетерогеност. MLST анализом је утврђено постојање шест нових
и три претходно детектована типа секвенце. Сојеви су били сензитиви на
све теститране антимикробне агенсе. Такође, код свих сојева је детектована
покретљивост пливањем, док ниједан није показивао друге типове
покретљивости. Међу сојевима који су показали способност адхезије на
муцин није уочена разлика између ЦФ и нЦФ изолата.
Већина изолата је показала способност формирања биофилма
(89,8%) и то подједнако заступљени су били представници ЦФ и нЦФ
групе. Анализом формирања биофилма у различитим условима раста
показано је да промена температуре и pH најјаче утиче на формирање
биофилма и то готово идентично на Цф и нЦФ сојеве. Применом
ТМП/СМX у коннцентрацији од 50 µg/ml долазило је до потпуне
разградње 24 сата старог биофилма, док је приликом примене 25 µg/ml тај
ефекат био завистан од соја. Код сојева који су формирали јак биофилм
уочена је спорија кинетика формирања биофилма код ЦФ у односу на
нЦФ сојеве. Шејкирање није утицало на формирање биофилма.
Велики генетички диверзитет међу изолатима указује да није дошло
до клоналног ширења унутар болнице. Показана је позитивна коерлација
између покретљивости, формирања биофилма и адхезије за мицин. Осим
тога, позитивна корелација је показана између покретљивости и јачине
формираног биофилма. Међутим, поређењем фенотипских
карактеристика ЦФ и нЦФ клиничих изолата уочава се да постоје разлике
разлике између ове две групе сојева, али не и ЦФ фенотип.
Ključne reči: Stenotrophomonas maltophilia, нозокомијалнa инфекција,
триметоприм-сулфаметаксазол, biofilm, PFGE, MLST
Naučna oblast:Молекуларна биологија
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1.  INTRODUCTION 
Stenotrophomonas maltophilia is an aerobic, non-sporulating, non-
fermentative, motile, Gram-negative road shaped bacterium, found in various 
environmental sources, including water, soil, plant, animal and organic 
residues. In addition, it has been found in the hospital environment and homes. 
Detected in a wide range of ecosystems, its degradation capabilities enhanced 
research in possible biotechnological applications like plant growth promoting 
bacterium (PGPB) and biocontrol organism. In the last decade, general interest 
for S. maltophilia rose, since it was connected with a wide range of hospital-
acquired infections, particularly pneumonia and bacteremia in debilitated, 
immunosuppressed patients, transplant recipients and in patients with cystic 
fibrosis. Although this organism is nonpathogenic in healthy individuals, it is 
considered as an important opportunistic pathogen increasingly associated with 
morbidity and mortality in susceptible people. In the last decade, it was 
classified in the group of emerging, Gram-negative, multiple drug resistant 
(MDR) organisms. S. maltophilia is intrinsically resistant to many broad-
spectrum antibiotics including β-lactam antibiotics (including imipenem), 
quinolones, aminoglycosides, carbapenems, and tetracyclines. The variety of 
clinical patterns associated with S. maltophilia infection continues to increase. 
There are numerous virulence factors, which are associated with the 
pathogenicity of this bacterium such as adhesion capacity, biofilm formation, 
hydrophobicity, motility and synthesis of extracellular enzymes. Additionally, 
there is still a considerable doubt regarding the acquisition routes of S. 
maltophilia infection, although a number of sources in the hospital setting have 
been recognized, strains isolated from these sites vary from strains that 
obtained from clinical materials. 
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1. Stenotrophomonas maltophilia – classification, 
microbiology characteristics and identification 
1.1. Classification 
Taxonomy of the Genus Stenotrophomonas: 
Domain Bacteria 
Phylum Proteobacteria 
Class Gammaproteobacteria 
Order Xanthomonadales 
Family Xanthomonadaceae 
Genus Stenotrophomonas (Palleroni & Bradbury, 1993) 
Species Stenotrophomonas maltophilia 
The species Stenotrophomonas maltophilia was originally isolated in 
England from human pleural fluid in 1943, named as species Bacterium booker, 
genus Alcaligenes and it was reported as being non-motile and probably a skin 
contaminant. Later in 1961, after detail morphological, physiological and 
serological analysis it was reclassified as species Pseudomonas maltophilia, genus 
Pseudomonas. Analyzed strain was isolated in 1958 from an oropharyngeal swab 
from a patient with an oral carcinoma (Hugh and Ryschenkow, 1961). In 
parallel, Pseudomonas melanogena isolated from Japanese rice paddies in 1963 
was later documented as Pseudomonas maltophilia. The use of DNA-rRNA 
hybridization techniques discovered the presence of five rRNA homology 
groups in the genus Pseudomonas, and the rRNA cistron analysis of the P. 
maltophilia ATCC13637 showed that it was similar to three Xanthomonas strains 
(Palleroni et al., 1973). This evidence was used by Swings and coauthors (1981) 
to suggest that P. maltophilia be reclassified in the genus Xanthomonas, species X. 
maltophilia. Furthermore, they mentioned several other factors to support this 
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observation. Some of them are guanine-cytosine (GC) content (P. maltophilia, 63 
to 67.5%; Xanthomonas, 63 to 70%); enzymes comparison, particularly the lack of 
NADP-dehydrogenases; the rate of the same type of ubiquinones (P. maltophilia 
and Xanthomonas spp. both possess ubiquinones with eight isoprene units, 
whereas all other Pseudomonas strains possess nine units); and similar fatty acid 
and proteins composition. Additionally, studies of outer membrane esterase, 
established that P. betle and P. hibiscicola were synonyms of X. maltophilia 
(Debette et al., 1989, Singer et al., 1994). Later, Yang and coauthors (1993) using 
polyamine and fatty acid analysis, demonstrated that X. maltophilia possess 
profiles distinct from other species within the genus Xanthomonas. As well as, 
the possession of ubiquinones with eight isoprene units was shown unlimited 
to X. maltophilia and other members of the genus Xanthomonas (Oyiazu and 
Komagata, 1983). This was supported by another experiment with a 
Xanthomonas specific 16S rDNA sequence (Maes, 1993). Xanthomonades were 
recognized by the presence of a single 480 bp PCR fragment in which, X. 
maltophilia strains produced additional PCR fragments, leading to 
reinterpretation that X. maltophilia does not belong to the genus Xanthomonas. 
These findings, along with additional evidence, were used to reclassification of 
this bacterium Xanthomonas maltophilia in 1993 to create the new genus 
Stenotrophomonas with the sole member species Stenotrophomonas maltophilia 
(Palleroni & Bradbury, 1993). Drancourt and coauthors (1997) suggested a new 
species Stenotrophomonas africana, which is identical biochemically to S. 
maltophilia with some exceptions. However, the genotypic analysis revealed 
only 35% DNA homology between the two species. Today genus 
Stenotrophomonas contains not only S. maltophila but also other species: S. 
nitritireducens, S. rhizophila, S. acidaminiphila, S. koreensis, S. dokdonensis. S. humi, 
S. terrae, S. chelatiphaga, S. ginsengisoli, S. daejeonensis, S. pavanii and S. tumulicola 
(http://www.bacterio.net/stenotrophomonas.html). 
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The name Stenotrophomonas is from the Greek origin – stenos (sample), 
trophos (the one that is feed), and monos (unit). It describes the organism that can 
survive in the moisture surfaces that are rich with nutrients. Word maltophila in 
its root contains two words maltum (crops) and philia (affinity) (Conly and 
Shafran, 1996). 
1.2. Microbiology characteristics 
S. maltophilia is an aerobic, non-sporulating, non-fermentative, motile, 
Gram-negative, road shaped, bacterium, 0.7–1.8 × 0.4–0.7 μm in size. It is 
catalase positive, oxidase negative bacteria; although recent data point that, 
some S. maltophilia isolates are oxidase positive. Bacterial surface is covered 
with tin febrile structures (5 to 7 nm) and there are few polar flagella (40 to 50 
nm), which are used for movement of bacteria (Brooke, 2012). Under 
microscope they can be seen as individual cells or in pares. On hard medium in 
Petrie dishes, they form smooth, round colonies with sharp edges, from white 
to light yellow color, while in MacConkey agar plates it produces dark pigment 
and form colonies with characteristic look. For the optimal growth for most of 
the strains from genus Stenotrophomonas amino acids, methionine and cysteine 
are necessary (Denton and Kerr, 1998). It does not grow at temperatures lower 
than 4°C or higher than 41°C and its optimal growth temperature is 35°C. 
S. maltophilia is ubiquitous microorganism, thanks to its adaptability and 
resistance widely distributed in the environment. It is associated with aqueous 
sources both inside and outside the houses (lakes, rivers, water treatment and 
distribution systems, wastewater plants, sinkholes, tap water, bottled water). S. 
maltophilia was also isolated from soil, plant rhizosphere, animals. In addition, 
there was an increase in the isolation of S. maltophilia in hospital settings during 
last decade. It is opportunistic pathogen commonly associated with healthcare-
associated infections in immunocompromised patients. S. maltophilia is the only 
representative of the genus Stenotrophomonas that is connected with human 
INTRODUCTION 
6 
infections, while other species are plant pathogens. In the last decade, it was 
classified in the group of emerging, Gram-negative, multiple drug resistant 
(MDR) organisms (Brook, 2014). In the hospital surroundings, it also colonizes 
suction tubing, catheters, hemodialysis water and other medical and non-
medical equipment. Due to its low number, this bacterium usually led to 
colonization but not to infection of the humans. The most frequent place of 
colonization is respiratory tract of patients and in patient with hematological 
malignancy; a fecal content of S. maltophilia is increased (Denton and Kerr, 
1998). From particular importance is its ability to form biofilm on different 
biotic and abiotic surfaces, which could lead to development of the infection 
(Nicodemo and Paez, 2007). Particularly sensitive are patients with cystic 
fibrosis, where it can colonize airways and cause chronic infections (Goncalves-
Vidigal et al., 2011). However, the most common infections associated with S. 
maltophilia include respiratory tract infections, bacteremia, catheter-related 
infections and urinary tract infections, infections of skin and soft tissues, 
endocarditis, meningithis, intraabdominal infections, eye infections and others 
(Denton and Kerr, 1998; Nicodemo and Paez, 2007). 
1.3. Identification 
Isolates of S. maltophilia could be identified with standard 
microbiological methods, according their morphological characteristics, growth 
conditions, biochemical (pigment production, oxidase test, catalase tests, etc.) 
and physiological characteristics. However, for the precise identification it is 
necessary to use molecular biology techniques: 
 Sequencing of the genes for 16S rRNA and 23S rRNA 
 PFGE („Pulsed-Field Gel Electrophoresis”) 
 DDH („DNA-DNA hybridization”) 
 MLST („Multilocus Sequence Typing”) 
 AFLP („Amplified Fragment Length Polymorphism”) 
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 RFLP („Restriction Fragment Length Polymorphism”) gyrB gene 
and other. 
For final molecular identification of S. maltophilia isolates, but this is also 
the usual practice for all other bacterial species, it is necessary to use two or 
more methods. In addition, S. maltophilia may be coupled with polymicrobial 
infections or can grow slower in the host, which make the isolation and 
identification of this bacterium more difficult. Scientists have mainly relied on 
PCR based method, e.g. sequencing of the 16S rRNA gene that is conceder as 
the most conserved gene of three rRNA molecules (5S, 16S and 23S). In 
addition, it has been suggested as an “evolutionary clock”, which has led to the 
rebuilding of the tree of life (Woese, 1987). Sequencing of PCR products of 
amplified 16S rRNA gene was the main method on which scientist are rely on 
in the last two decades for the final identification and classification of bacteria. 
In addition, sequencing of intermediate region between 16S and 23S rRNA 
gene, was useful method for identification and determination the differences 
between some bacterial species or sequencing of the 23S rRNA gene alone, 
which was useful for Streptococcus identification (Clarridge, 2004). 
For identification, both Gram-positive and Gram-negative bacteria very 
useful method is Pulse Field Gel Electrophoresis (PFGE). This method was 
described for the first time in 1984 as the method for analysis of genomic DNA 
of eukaryotic organisms, while today is one of the main methods for 
identification of different bacterial species (Tenover et al., 1997). It is based on 
separation of DNA fragments of large molecular weight, which are obtained 
after digestion of bacterial DNA with selected restriction enzymes. During 
PFGE, direction of electronic field is changed periodically (pulse) what enables 
large fragments to pass through gel and be separated. Obtain macrorestriction 
profiles is strain specific, sometimes species specific, and for genotyping of S. 
maltophilia, the genomic DNA was digested with XbaI enzyme (Tenover et al., 
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1997). To examine local epidemiology infections with S. maltophilia the most 
frequently used methods are PFGE and RAPD – PCR, while for analysis of 
global epidemiology MLST is the method of choice (Kaiser et al., 2009). 
Multilocus Sequencing Typing (MLST) are based on comparison of 
nucleotide sequences of seven housekeeping genes and for S. maltophilia those 
genes are atpD (H (+)-transporting two-sector ATPase), gapA (NAD-dependent 
glyceraldehyde-3-phosphate dehydrogenase), guaA (GMP synthase), mutM 
(DNA-formamidopyrimidine glycosylase), nuoD (NADH dehydrogenase), ppsA 
(pyruvate, water dikinase), recA (RecA protein). Each strain is specific with its 
sequence type (ST) which is representation of the unique combination of seven 
housekeeping genes. Due to high specificity and discriminatory potential this 
method is used more and more frequently, although expensiveness and 
complex methodology limit its everyday use in microbiological laboratories. 
2. Clinical importance of S. maltophilia 
2.1. Epidemiology 
From the time when the genus Stenotrophomonas was, established 
bacteria from this genus were mainly associated with different plants, what is 
implemented in the name of the genus and species. Some of the species cause 
plant diseases while the other are typical endophyte which have PGP effect on 
plants or they could help them to survive in the harsh environment (Ryan et al., 
2009). Biotechnological potential of S. maltophilia was described in many papers 
(Alavi et al., 2013) and he was used as biocontrol agents up until the 1980s. 
However, in the early 1980s, S. maltophilia was reported as a new pathogen in 
the hospitals and now it is classified as an emerging, global, MDR opportunistic 
pathogen (Ryan et al., 2009; Brook, 2012). How this happen? Continuous 
development of the medical sciences with more aggressive why of diagnostics 
and therapy of many diseases, wider use of antibiotics (especially carbapenems) 
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led to increase in the isolation of S. maltophilia in hospitals. As an opportunistic 
pathogen, it does not infect healthy people. However, now we know that 
immunodeficiency (malignancy, chronic diseases, use of cytostatic and 
immunosuppressive therapy, neutropenia, burns, etc.), long hospitalization 
especially in the intensive care units, use of central venous and/or urinary 
catheter, intubation or tracheotomy, transplantation of artificial implants and 
prosthesis, in combination with overuse of broad spectra antibiotics are the 
main risk factors for infection with S. maltophilia and other hospital bacteria 
(Looney, 2005). 
S. maltophilia usually causes pneumonia mostly in patients with chronicle 
respiratory diseases with long period-applied mechanical ventilation. Clinically 
important bacteremia is less frequent while infections of blood-stream infection, 
urinary and gastrointestinal tract, skin and soft tissues are rare (Looney, 2005). 
According to the clinical analysis, infections caused with S. maltophilia are not 
different from other hospital infections caused with clinical pathogens in 
immunodeficiency patients. Morbidity connected with these infections is hard 
to estimate since they are usually occurred in sever patients. Available data 
showed that morbidity as an effect of infection is found in 10-40% of patients 
(Sattler et al., 2000; Lai et al., 2004). 
S. maltophilia is an environmental organism, which has also been isolated 
from human, animal feces, frozen fish, woodland ticks and milk. S. maltophilia 
has been found in the hospitals as a contaminant of medical devices, 
chlorhexidine-cetrimide disinfectant, edetic acid anticoagulant in vacuum-blood 
collection tubes, and sterile water (Spencer, 1995). High genomic diversity of 
the isolates obtained in previous studies (Valdezate et al., 2004) with rare 
exception (Garciá de Viedma et al., 1999) leads to the conclusion that patients 
were the route of introduction of the S. maltophilia to the hospital setting. This is 
suggesting that most patients acquire S. maltophilia from an independent source, 
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possibly before hospital entry, and the bacterium is then selected from the 
commensal flora (Caylan et al., 2004; Kagen et al., 2007). 
2.2. Antibiotic resistance 
Antibiotics are natural organic compounds produced by microorganisms 
that inhibited growth and kill other microorganisms. They are product of 
secondary metabolism, synthesized in the stationary phase of growth and 
selectively kill prokaryotic but not mammalian cells. Thanks to those 
characteristics, they are used for therapeutic purposes (Topisirović and Jovčić, 
2013). According to the mechanism of action, antibiotics can be divided on 
inhibitors of: intracellular enzymes, bacterial wall synthesis, citoplasmatic 
membrane functions, nucleic acid synthesis and protein synthesis. The rising 
problem all over the world is the quick spreading of antibiotic resistance 
between different bacteria species. This problem becomes even greater since 
some strains develop multidrug resistance (MDR). The antibiotic resistance is 
acquired by the horizontal transfer of plasmids, transposons, integrons, 
integron-like elements, insertion elements common region (IECR) and biofilms 
(Topisirović and Jovčić, 2013; Looney, 2005). There is an urgent need for the 
new approach in the treatment of these bacteria. Synergy between antibiotics 
and different antimicrobial peptides, search for new antimicrobials or 
development of new antibiotics is some of the area of scientific research 
(Mataraci and Dosler, 2012). 
2.2.1. Mechanism of resistance 
S. maltophilia shows a high level of intrinsic and acquired resistance to 
various antibiotics such as β-lactam antibiotics (including imipenem), 
macrolides, quinolones, aminoglycosides, carbapenems, and tetracyclines, 
chloramphenicol, polymyxins, while trimethoprim–sulfamethoxazole 
(TMP/SMX) has been recognized as the antibiotic of choice in the treatment of 
these bacteria (Sánchez, 2015). Although, first it was thought that MDR in S. 
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maltophilia comes from hospital settings now we know that it was acquired in 
the natural nonhuman environment (Martínez, 2008; Sánchez, 2009). However, 
it can be broadened in the hospital settings through interactions with other 
hospital bacteria. In the last decades, intensive use in combination with misuse 
of antibiotics in the countries with poor regulation, not only for the human 
treatment but also in veterinary medicine led to contamination of the 
environment with antibiotics. This led to a higher incidence of antibiotic 
resistant bacteria or MDR bacteria and faster spread of resistance by other 
bacteria to pathogens (Cattoir et al., 2008). Numerous molecular mechanisms 
contribute to S. maltophilia antibiotic resistance, including, integrons, plasmids 
and transposons (Barbolla et al., 2004). Reduction in outer membrane 
permeability and β-lactamases contributes to resistance to β-lactams (Cullmann, 
1991; Avison et al., 2001; Mercuri et al., 2002), presence of chromosomally 
encoded multidrug resistance efflux pumps (Gould et al., 2004), and antibiotic-
modifying enzymes (Li et al., 2003) all contribute to the intrinsic antibiotic 
resistance of S. maltophilia clinical isolate (Sánchez et al., 2009; 2012; 2015). 
2.2.1.1. Resistance to β-lactam antibiotics 
β-lactam antibiotics disable peptidoglycan synthesis in the final step of 
bacterial cell wall synthesis. Their main targets are enzymes transpeptidase and 
carboxypeptidase that catalyze the reaction of peptidoglycan synthesis. These 
enzymes are also known as penicillin binding proteins-PBPs, since previously it 
was discovered that they bind penicillin. Binding of the antibiotic for the active 
site of enzyme led to formation of enzyme-antibiotic complex, which inhibits 
enzyme activity. This led to weakness of the peptidoglycan synthesis, inhibition 
of the bacterial growth and finally to the cell lyses (Wilke at al., 2005). 
Resistance to β-lactam antibiotics become usual for both Gram-negative and 
Gram-positive bacteria and are a consequence of antibiotic inactivation, target 
changes, lower membrane permeability or efflux pumps. Most frequent way is 
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synthesis of the β-lactamase, enzyme that degrades β-lactam antibiotics. Genes 
for β-lactamase could be located on plasmid, chromosomal DNA, transposons 
or integrons. The most relevant clinical β-lactamse is AmpC enzymes, Extended 
Spectrum Beta Lactamase – ESBL and carbapenemase. 
Resistance of S. maltophilia on β-lactam antibiotics is due to synthesis of 
two types of β-lactamase, L1 and L2, whose genes are located on 200 kb 
plasmids. Interestingly, not all clinical isolates synthesized β-lactamase. The β-
lactamase L1 is metallo-β-lactamase a homodimer of 118 kDa. It is a Zn2+-
dependent metalloenzyme that hydrolyzes almost all classes of β-lactams, 
including cephalosporins, penicillins, and carbapenems except monobactam, 
and it is not inhibited by clavulanic acid. The serine β-lactamase L2 is 
cephalosporinase that hydrolyzes aztreonam, it is a clavulanic acid-sensitive 
cephalosporinase (Walsh et al., 1997). 
2.2.1.2. Resistance to aminoglycoside 
Aminoglycosides are large and for chemotherapy important group of 
antibiotics, from streptomycin to highly potent amikacin and netilmicin. They 
are broad-spectrum antibiotics that inhibit protein synthesis in huge number of 
bacteria. However, their clinical importance is less and less since the number of 
resistance bacteria is increased dramatically. Many studies suggest that 
multiple mechanisms may contribute in aminoglycoside resistance by S. 
maltophilia, such as temperature-dependent resistance due to outer membrane 
changes, aminoglycoside-modifying enzymes, the efflux-mediated mechanism, 
and target modification which has been reported in some Gram-negative 
pathogens (Magnet and Blanchard., 2005). A family of enzymes that include O-
phosphotransferases, O-nucleotidyltransferases, and N-acetyltransferase are 
responsible of aminoglycoside enzymatic modification. The changing in the 
lipopolysacharide (LPS) structure has been connected with changes in 
resistance to a variety of antimicrobial agents (Poole, 2002). It has been showed 
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the capability of S. maltophilia to modify the size of O-polysaccharide and the 
phosphate content of LPS at different temperatures, which increases the 
resistance to aminoglycosides at 30°C compared to 37°C (McKay et al., 2003). In 
addition, S. maltophilia also has several heavy-metal resistance mechanisms, and 
can tolerate silver-lined catheters. 
2.2.1.3. Resistance to quinolones 
Quinolones are synthetic broad-spectrum antibiotics that inhibited DNA 
replication by inhibiting enzyme DNA gyrase. There are three generations of 
these antibiotics, first are nalidicic acid, cinocoxain and pipemidic acid, second 
are norfloxacin, ciprofloxacin, lomefloxacin, ofloxacin, levofloxacin, etc. and 
third are gatifloxacin and moxifloxacin (Topisirović and Jovčić, 2013). The most 
frequent cause of S. maltophilia resistance on quinolones is specific mutation in 
the quinolone-resistance determining regions – QRDR inside the subunit for 
DNA gyrase enzyme (GyrA, GyrB) and (ParA, ParC). In addition, resistance on 
quinolones in S. maltophilia could be from reduction in outer membrane 
permeability and multidrug resistance efflux pumps (Valdezate et al., 2002). 
2.2.1.4. Multidrug resistance efflux pumps 
Multidrug resistance efflux pumps have been recognized as an 
important resistance mechanism in S. maltophilia. It is composed of membrane 
fusion proteins, an energy dependent transporter, Outer Membrane Proteins - 
OMPs. In general, they are responsible for secretion of antibiotics and toxins 
produced by bacterial cell and excretion of the compounds that came from 
surroundings to bacterial cell (antibiotics, disinfectant, colors, detergents, etc.) 
(Askoura et al., 2011). Genes that encodes efflux pump proteins are located on 
plasmids and chromosomal DNA. In S. maltophilia there are a few types of 
efflux pumps SmeABC, SmeDEF, SmeJKL and SmeYZ (Tanimoto, 2013). Genes 
from SmeDEF operon encodes genes responsible for resistance on β-lactams, 
tetracyclines, erythromycin, quinolones, aminoglycoside and choramphenicol 
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(Brooke, 2012; Nicodemo and Paez, 2007). S. maltophilia isolates rapidly develop 
resistance mechanisms against fluoroquinolones by making mutations in outer-
membrane proteins. Recently study established the involvement of efflux 
mechanisms in acquired multidrug resistance in S. maltophilia (Zhang et al., 
2000). 
2.3. Selection of antimicrobial agents 
The proper selection of antimicrobial agents for the treatment of S. 
maltophilia infection is a challenge in increased resistance prevalence and a high-
level intrinsic resistance of this opportunistic pathogen. Recent treatment 
recommendations are based on historical evidence, case series and case reports, 
and in-vitro susceptibility studies. It is possibly wise to select a treatment 
program to which the clinical isolate is susceptible in in vitro tests, despite 
doubts about the clinical significance of such results. The drug of choice for 
treatment of S. maltophilia infections according to the World Health 
Organization is trimethoprim-sulfamethoxazole (TMP-SMX). However, there is 
increased number of reports from different hospitals about the resistance to 
TMP-SMX and susceptibility decreased from more than 98% to 30-40% 
(Toleman et al., 2007). Molecular mechanisms contributing in resistance of S. 
maltophilia to TMP-SMX are the class 1 integrons (Barbolla et al., 2004). Part of 
the class 1 integron are sul1 gene found in TMP-SMX resistant S. maltophilia 
isolates recovered from Spain, Italy, Turkey, Germany, North and South 
America and sul2 gene found on plasmid and chromosomal DNA in S. 
maltophilia TMP-SMX resistant isolates. Some sul2 genes are connected to ISCR2 
elements (Toleman et al., 2007). Vartivarian and coauthors (1994) reported an 
increase in the TMP-SMX susceptibility of isolates over 12-year period at the M. 
D. Anderson Cancer Center where there is discontinuation of its use as a 
common agent for antibacterial prophylaxis. Furthermore, they observed an 
increase in resistance to the quinolones the antibiotics that replaced TMP-SMX 
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in this treatment over the same period. Recent study suggests that a 
combination of TMP-SMX and either ticarcillin – clavulanate or cephalosporin 
may be superior to TMP-SMX alone (Muder et al 1996). Ticarcillin-clavulanate 
has been noted to display good activity against S. maltophilia, and it has been 
suggested that this agent should be used with individuals intolerant of TMP-
SMX. Tigecycline and levofloxacin, alone or in combination, have shown 
promising efficacy in the treatment of S. maltophilia infections (Farrell et al., 
2010; Wang et al., 2014). New treatment strategies point out the need for finding 
new and more effective antibiotics or selection of synergy antibiotics. In 
addition, search for new antimicrobial agents (lipopeptides, plant oils, 
bacteriocins and other antimicrobial peptides) and it use in combination with 
conventional antibiotic is also new area of scientific research. In vitro models 
suggest that antimicrobial combination therapy would be more effective than 
monotherapy particularly for treatment of difficult infections.  
3. Molecular mechanisms involved in pathogenesis of 
S. maltophilia 
Although molecular mechanisms involved in pathogenesis of S. 
maltophilia are not all discovered the main factors for the pathogenicity of S. 
maltophilia are adhesion capacity, biofilm formation, hydrophobicity, motility, 
and synthesis of extracellular enzymes (Pompilio, 2010; Looney, 2005). 
3.1. Adhesion capacity 
Adhesion capacity of bacterial cells is the first factor involved in the 
process of initial colonization and invasion to the tissue of the host or abiotic 
surfaces. Interaction between bacterial cell and epithelial cell is through flagella 
and/or pile on the bacterial surface (Looney, 2005). Positive charge of the 
bacterial surface is also one of the main factors which goes in favor to adhesion 
INTRODUCTION 
16 
and colonization of biotic (host tissue) and abiotic (plastic, glass, Teflon, 
medical devices, etc.) surfaces (Di Bonaventura et al., 2008). McKay and 
coauthors (2003) showed that spgM gene which encodes bifunctional enzyme 
that has both phosphoglucomutase and phospomannomutase activity is 
necessary for the tissue colonization with S. maltophilia. This enzyme is involved 
in synthesis of lipopolysaccharides that on the other hand have influence on the 
cell adhesion. Adhesion of S. maltophilia on abiotic surfaces enables direct or 
indirect contact of bacteria with the patient. For example, colonization of the 
endotracheal tubus with S. maltophilia enables direct entrance of bacteria into 
the patient’s lungs and on that why influenced pathogenesis of pneumonia. In 
addition, bacteria could easier multiply inside of the tubus since that surface is 
not protected by the immune system cell and antibiotics do not have effect on 
them too (Looney, 2005). The adherence of bacterial cells to a surface is one of 
the early steps in biofilm formation process. 
3.2. Biofilm 
Biofilm formation is an important factor of bacterial virulence and 
pathogenesis, which usually contribute to the diseases progression. Biofilm is a 
highly organized, multicellular community of microorganisms encased in an 
extracellular polymeric matrix, made from polysaccharides and proteins that 
are affixed to a biotic or abiotic surface. Bacterial populations within a biofilm, 
as opposed to their planktonic counterparts, have a reduced growth rate and a 
distinct transcriptome. Moreover, they exchange genetic material at an 
increased frequency thereby augmenting their ability to acquire traits favorable 
to their persistence (Donlan and Costerton, 2012). Biofim protects 
microorganisms from the immunity system of host and from influence of some 
antimicrobial substances (Pompilio, 2010; de Oliveira-Garcia, 2002). Physical 
and molecular interactions that govern the adhesion of bacteria to these 
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surfaces require an understanding of specific and non-specific interactions 
(Oztuna et al., 2006). 
Changing from planktonic growth to biofilm populations is due to 
response to the changes in the bacteria environment. It involves a huge 
regulatory network that translates signals which regulate genes expression 
causing cell reorganization (Kostakioti et al., 2017). This cellular 
reprogramming includes the expression of surface molecules, adapting the use 
of nutrients, expression of virulence factors, and equipping the bacteria with an 
arsenal of properties that allow them to survive under unfavorable conditions 
(Lenz et al., 2008). 
Bacterial aggregation and biofilm maturation consists of reversible and 
irreversible levels involving numerous and specific factors. There are two basic 
processes in the formation of biofilm. The first phase involves binding of 
bacteria to the surface, followed by the second phase of aggregation of bacteria 
and the formation of multilayer structures. Bacteria in biofilm are associated 
with amorphous mucous material so called extracellular polysaccharide matrix 
(Gotz, 2004), which plays a special role as a cellular adhesive, which makes the 
layers sticky, tolerant to the environmental factors (Rode et al., 2007) and 
antimicrobial agents (Heiby et al., 2010). Within the biofilm there is a developed 
network of water and nutrient channels, thus providing cells with conditions 
for growth and diversity (Watnick and Kolter, 2000). 
According to the information so far, more than 99% of the bacteria in the 
natural environment live in biofilm, and in 80% of cases of infection in humans, 
biofilm plays an important role (Stewart PS, 2001). In that sense, S. maltophilia is 
involved in approximately 65% of hospital-associated infections (Mah and 
O'Toole, 2001). Di Bonaventura et al. (2010) showed that S. maltophilia SM33 
cells could adhere within 2h to polystyrene surfaces and form biofilms within 
24 h of inoculation. Both the transmission and scanning electron microscopy 
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(TEM and SEM) recognized the S. maltophilia flagella on 46 clinical isolates, 
which suggest that the flagella and other thin pili arrangements are involved in 
adherence of bacterial cell on a plastic surface (de Oliveira-Garcia et al., 2002). 
Previous study has determined that S. maltophilia can form biofilm on 
lung cells. The mucus that lining the surfaces of the respiratory, gastrointestinal, 
and reproductive systems provides a barrier against pathogens. It contains 
glycoproteins, which are composed of a peptide backbone that associated to 
carbohydrates, which act as a receptor for bacterial adhesions (Arora et al., 
1998). The biofilms formed by cystic fibrosis (CF) isolate S. maltophilia OBGTC9 
on CF sputum-derived bronchial epithelial IB3-1 cell monolayers showed that S. 
maltophilia formed microcolonies embedded in extracellular matrix (Pompilio et 
al., 2010). Interestingly, biofilm formed by S. maltophilia CF isolates on 
polystyrene surface did not resemble to the biofilm formation by the isolates on 
the cell monolayer. That evidence supports the thought that biofilm formation 
on abiotic surfaces may not reflect the biofilm formation on biotic surfaces. 
Furthermore, the environmental factors that can influence the biofilms 
formation by S. maltophilia include temperature, pH, phosphate, chloride 
concentrations, aerobic and anaerobic conditions, and the presence of silver and 
copper ions (Di Bonaventura et al., 2007; Critchley et al., 2003). S. maltophilia can 
form biofilms on wet surfaces that may contact direct or indirect with patients, 
including, dental suction tubing, water plumbing systems, respiratory tubing 
and unit waterlines, clinical sink drains, catheters, intravenous lines, dialysis 
equipment and domestic sink drains. It has been identified that the presence of 
sodium phosphate can alter the biofilms of clinical S. maltophilia isolates (Brooke 
et al., 2009). A study established that 9 of 11 clinical isolates have altered biofilm 
formation when cultured in Luria Bertani broth (LB) medium supplemented 
with sodium phosphate buffer (SPB). These findings have significance for 
applied situations where S. maltophilia may possibly form biofilms. Since for the 
phosphate has been demonstrated to alter the microbial communities in the 
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human water supply, the levels of sodium and phosphate in hospital water 
plumbing systems should be observed (Goss et al., 2004). 
Clinical S. maltophilia isolates have been detected to form biofilms at 32°C 
more than at 18°C and 37°C (Di Bonaventura et al., 2007). The formation of 
biofilm was higher under aerobic conditions and in a 6% of CO2 atmosphere 
than the biofilm formation under anaerobic conditions. The S. maltophilia 
isolates have reported to produce comparable biofilms at pH 8.5 and 7.5 and 
higher biofilm produced at pH 5.5 (Di Bonaventura et al., 2007). 
3.2.1. Factors associated with biofilm formation in S. maltophilia 
The environmental factors affecting S. maltophilia biofilm formation have 
been investigated, but the molecular basis of their regulatory mechanisms 
remains incompletely understood (Di Bonaventura et al., 2004; Di Bonaventura 
et al., 2007; Stoodley et al., 1999) and thus far only a few related S. maltophilia 
genes have been experimentally studied. For example, several structural genes 
associated with the cell envelope, including those encoding the proteins 
involved in lipopolysaccharide/exopolysaccharide-coupled biosynthesis (rmlA, 
rmlC, and xanB) and the pump-encoding genes macABCsm and smeYZ have 
been identified as necessary for biofilm formation (Huang et al., 2006; Lin et al., 
2014; Lin et al., 2015). In addition, the genes encoding three transcription 
regulators (fleQ, fsnR, and bfmA) also control biofilm development. FleQ binds 
to the putative ATPase FleN to form a complex that directs flagellar gene 
expression (Yang et al., 2014). FsnR, designated as a response regulator with 
transcription-regulating activity, binds directly to the promoter regions of gene 
clusters involved in flagellar assembly to activate their transcriptional initiation 
(Kang et al., 2015; Zheng et al., 2016). Besides the aforementioned regulatory 
factors, recent studies have identified bis-3′, 5′-cyclic diguanosine 
monophosphate (c-di-GMP) as an important cellular second messenger broadly 
distributed among bacteria and critical to the control of bacterial physiology, 
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especially biofilm development and motility. c-di-GMP activates downstream 
cascades by binding to specific protein effectors or riboswitches embedded in 
the leader regions of mRNAs. 
3.3. Synthesis of extracellular enzymes 
Different extracellular enzymes including DNase, RNase, fibrinolysin, 
lipases, hyaluronidase, protease, hytinase, mucinase, elastase, may play a role 
in the pathogenesis of S. maltophilia associated infection. Bottone and coauthors 
(1986) reported a case of ecthyma gangrenous in a leukemic patient with S. 
maltophilia bacteremia. Since the production of protease and elastase by bacteria 
is considered an important in the pathogenesis of cases of ecthyma gangrenous 
associated with P. aeruginosa septicemia, they studied the S. maltophilia isolate 
for elaboration of these enzymes and established that it was an “avid protease 
and elastase producer” (Bottone et al., 1986). A study of 52 clinical and 
environmental strains tested for the production of nine extracellular enzymes 
showed that there is no production of lecithinase, hyaluronidase, or chondroitin 
sulfatase by any strains, however all of them produced protease and elastase. 
Production of elastase was variable, but there was no significant variation 
between clinical and environmental strains. Even though DNase, fibrinolysin 
and lipase were produced by all strains at 20°C, the clinical isolates showed 
higher production of these enzymes at 37°C. Moreover, the ability of the 
bacterium to grow in dialysis fluids and release their low molecular- weight 
pyrogens, might be important in the pathogenesis caused by the pyrogenic 
reactions during hemodialysis (Ganadu et al., 1996). A study reported that S. 
maltophilia clinical isolates were much more likely to exhibit this property than 
environmental isolates (Denton et al., 1998). 
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3.4. Hydrophobicity and motility 
The interaction of microorganisms with different host organisms as well 
as with the environment is mediated through their surface; therefore, surface 
properties are important for these interactions. The behavior of microorganisms 
in different environment is largely determined by the composition and 
characteristics of their surface. This determined their adhesion capacity, 
colonization, biofilm formation and finally development of infections (Di 
Bonaventura et al., 2008). When microorganisms come to interaction with 
abiotic or biotic surface destiny of that interaction depends of nonspecific, 
especially hydrophobic interactions (Costa et al., 2006). A positive correlation 
was observed between cell surface hydrophobicity and adhesion and biofilm 
formation of S. maltophilia (Pompilio et al., 2008). Surface hydrophobicity is 
especially important in interactions with abiotic surfaces, in particular those 
found in hospital environments. However, isolates with different 
hydrophobicity characteristics could have similar biofilm formation ability 
what goes in favor that multiple factors affect biofilm formation. 
Cell surface structures flagella, pili, fimbriae play an important role in 
adhesion capacity, colonization and biofilm formation in different 
microorganisms (Mandlik et al., 2008). S. maltophila is characterized with 
different structural appendages such as flagella and pili that both enable 
different types of motility to this bacterium (swimming, swarming and/or 
twitching) but also biofilm formation (De Oliveira-Garcia et al., 2002, 2003). 
Pompilio and coauthors (2008) did not found any correlation between motility 
and hydrophobicity, adhesion capacity and biofilm formation. However, they 
showed relationship between amount of biofilm formed and the extent of the 
initial adhesion. This finding suggests that first step in biofilm formation of S. 
maltophila is adhesion of bacteria to abiotic surfaces. 
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4. Cystic fibrosis 
Cystic fibrosis (CF) is most frequent monoclonal inherited diseases 
(1:2500) of the white race people that is inherited in an autosomal recessive 
manner, and with high frequency (4-5%) of heterozygote carrier in human 
population (Govan and Deretic, 1996). A chronic, progressive, and multisystem 
disease is a consequence of one or more mutation in cftr gene. This gene 
encodes cystic fibrosis transmembrane conductance regulator, CFTR, which 
form chloride channel, which regulated transport of the ions through cell 
membrane. Mutations in this gene led to disturbance of Na+ and Cl– ions 
transport, dehydration of secret that normally cover airways forming viscose 
mucus layer which could not be easily excreted. This tick, viscose and high 
osmolarity secret “capture” bacteria and they increase their number, develop 
biofilm and cause chronic respiratory infections (Cantón and del Campo, 2010). 
Eradication of the respiratory tract due to chronic microbial colonization and 
infection is the main cause of morbidity and mortality of the CF patients. 
Interestingly, small number of microbes causes respiratory infections in CF 
patients, but they are usually polymicrobial (Rabin and Surette, 2012). In 
children, the most frequent cause of infections is Staphylococcus aureus and 
unencapsulated Haemophilus influenzae, while in adult’s opportunistic 
pathogens such as Pseudomonas aeruginosa, Stenotrophomonas maltophilia and 
Achromobacter xylosoxidans are isolated. In CF patients, not as a cause of 
respiratory infection Burkholderia cepacia complex (Bcc), Burkholderia gladioli, 
Ralstonia spp., Cupriavidus spp., Pandoraea spp., etc, could be found also 
(LiPuma, 2010). Isolation of some of these species is associated with bad 
prognosis of the disease but for another precise role is not determined (LiPuma, 
2010). Simple explanation of this disease would be that it is the consequence of 
(impaired mucociliary transport) inefficient elimination of microorganism from 
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respiratory tract. However, it is probably more complex process. Lower activity 
of surfactants and natural peptides with local antimicrobial activity makes 
chronicle bacterial colonization and infection easier, and defense of natural 
immunity system is lower (Cantón and Del Campo, 2010). There is a constant 
interplay between infection and inflammation in airways, which is a key point 
of lung disease in CF patients (Hector et al., 2016). 
4.1. S. maltophilia and cystic fibrosis 
Prevalence of S. maltophilia in CF patients worldwide has increase in the 
last decade (de Vrankrijker et al., 2010). However, the exact role of this 
opportunistic pathogen in CF patients is still undiscovered. Bacterial population 
in CF patients is exposed to a harsh environment and intensive antibiotic 
treatment so changes in population content as well mutation in microorganisms 
occur intensively causing the constant changes in bacterial population 
(Tenaillon et al., 1999). The best-studied microorganism from CF patients is P. 
aeruginosa were it was documented that hypermutation is a key mechanism for 
increased antibiotic resistance (Oliver and Mena, 2010). Although, there is still 
some uncertainness in the precise role of S. maltophilia in the CF patients, 
nowadays it is considered as emerging opportunistic pathogen in the CF 
patients (Brooke, 2012). Diversity of S. maltophilia isolated from chronically 
colonized CF patients is high (Vidigal et al., 2014). Vidigal and coauthors (2014) 
showed that mutation in analyzed isolates confirmed fast adaptation of this 
bacterium population in order to survive in the CF lung airways, but they could 
not find significant correlation between mutations and increasing antibiotic 
resistance as it was shown for Pseudomonas. Aforementioned, polymicrobial 
infections in CF patients additionally impeded analysis of specific role of each 
species as well as their mutual interactions and role in the development and 
prognosis of the disease. However, Pompilio and coauthors (2011) suggested 
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existence of “CF phenotype” since their results for phenotypic characteristics of 
CF isolates significantly differ from those obtained for non-CF isolates. 
4.2 Prevention of S. maltophilia infections 
A number of prevention strategies to avoid S. maltophilia infection have 
been recommended. These include prevention of using the wrong antibiotics, 
prolonged embedding of foreign devices, and an appropriate sterilization of 
respiratory therapy equipment, cardiopulmonary bypass apparatus, 
hemodialyzers, and ice-making machines. In addition, it may be to avoid 
drinking of noncarbonated bottled water. To avoid hospital associated 
infections of S. maltophilia, colonization or infection, wearing of gloves and 
strengthening of hand hygiene practices when handling contaminated 
respiratory excretions or wound drainage were recommended. Transfer of S. 
maltophilia from tap water to patients is the problem, which could be prevented 
with continual education about the hygiene practice of the health care personal. 
The cost-effectiveness of screening programs for S. maltophilia colonization in 
high-risk patients needs further examination before they can be recommended 
(King et al., 2010). Scientific research, which will allow better understanding of 
this bacterium and its characteristics, would help in preventing infections as 
well as their adequate treatment. Biofilm-related infections are a therapeutic 
challenge of modern medicine and preventing of primary adhesion would 
prevent biofilm formation, consequently, this would lead to its faster 
eradication. 
5. Future perspectives 
Stenotrophomonas maltophilia is classified in the group of emerging, global, 
MDR pathogens. Environmental bacterium involved in hospital settings were 
due to its tremendous ability to adopt to these new surroundings from 
occasional isolations become usual in polymicrobial infections. Multiple 
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intrinsic antibiotic resistance makes its treatment difficult and development of 
new strategies are needed. It is necessary to consider its ecology, way of transfer 
in hospitals and their controlled use of antimicrobials in order not to encourage 
the spread of antibiotic tolerant S. maltophilia strains. Number of 
immunosuppressed individuals is increased and this points to the need to 
monitor the worldwide global emerging pathogens such as S. maltophilia. The 
most important is identification of molecular mechanisms, which lie in the basis 
of persistence of opportunistic pathogens in environment and clinical settings. 
 AIMS 
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2. AIMS 
The prevalence of Stenotrophomonas maltophilia has increased in hospitals 
worldwide simultaneously with the appearance of a myriad of antibiotic 
resistant bacteria. One of the usually present virulence factors in pathogenic 
bacteria and opportunistic pathogens are ability to form biofilm. Therefore, 
biofilm-associated infections substantially affect human health, increasing 
antibiotic resistance of bacteria and making more challenging to combat with 
such infections. 
The main aim of this study is genotyping, antibiotic resistance and 
biofilm formation of S. maltophilia clinical isolates. 
On the basis of the above-mentioned specific aims of this research are: 
1. Molecular identification and genotyping of S. maltophilia clinical 
isolates by sequencing of 16S rRNA gene and Pulse Field Gel 
Electrophoresis (PFGE). 
2. Dendrogram construction based on the PFGE results and 
clustering collections of S. maltophilia clinical isolates 
3. Multilocus sequencing typing (MLST) analysis of representative of 
each cluster 
4. Analysis of antibiotic resistance of S. maltophilia clinical isolates by 
disc diffusion method for tetracycline, chloramphenicol, 
livofloxacin and ciprofloxacin 
5. Analysis of antibiotic resistance of S. maltophilia clinical isolates by 
microdilution method for trimethoprim/sulfamethoxazole 
(TMP/SMX) 
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6. Analysis of virulence factors of S. maltophilia clinical isolates: 
hydrophobicity, motility, ability to adhere to mucin and 
biofilm formation 
7. Determination of kinetics of biofilm formation for selected S. 
maltophilia strains 
8. Analysis of influence of temperature, pH, CO2 concentration and 
agitation on biofilm formation 
9. Testing influence of TMP/SMX on formation and preformed 
biofilm of selected S. maltophilia strains 
As the final aim of this study, we expect to determine differences 
between S. maltophilia strains isolated from patients with cystic fibrosis (CF) and 
non-CF patients, as well as potential determination of S. maltophilia CF-
phenotype. 
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3. MATERIALS AND METHODS
1. Bacterial strains used in this study
Stenotrophomonas maltophilia isolates used in this study are clinical
isolates from Institute for Mother and Child Health Care of Serbia "Dr Vukan
Čupić", a 400-bed university-affiliated pediatric tertiary care hospital in
Belgrade, Serbia. This institution is also referral hospital and is the national and
regional reference CF specialist center for pediatric and adult patients with CF
from Serbia, Montenegro and Bosnia and Hercegovina. All isolates were
isolated in the Laboratory for clinical microbiology, during the period from
April 2013 until April 2015. At least one isolate per patient was included, as
well as subsequent isolations that were considered phenotypically different or
were recovered with a time interval of more than 6 months. Isolates are from
patient with (CF) and without (non-CF) cystic fibrosis (CF) but with different
immunomodulatory, cancer, diabetes, neurological and other diseases. The
collection comprises 88 clinical isolates, 42 for CF and 46 from non-CF patients
(Table 1).
Table 1 – Clinical isolates of S. maltophilia used in this study
Strains CFstatus
Date of
isolation
Site of
isolation Strains
CF
status
Date of
isolation
Site of
isolation
4065 non-CF 11.4.2013 Throat swab 252FA non-CF 13.8.2013
Bronchial
swab
4111 non-CF 12.4.2013 Throat swab 8770 non-CF 16.8.2013 Throat
4199 non-CF 15.4.2013 Throat swab 10021 non-CF 20.9.2013 Tube
4477 non-CF 22.4.2013 Throat swab 10030 non-CF 21.9.2013 Throat swab
4619 non-CF 25.4.2013 Abdominalwound 10137
non-
CF 24.9.2013
Bronchial
swab
4810 non-CF 30.4.2013 Throat swab 11124 non-CF 19.10.2013 Throat swab
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4952 non-CF 7.5.2013 Throat swab 10668 non-CF 8.10.2013 Throat swab
5226 non-CF 13.5.2013 Throat swab 11370 non-CF 25.10.2013
Bronchial
swab
5365 non-CF 16.5.2013 Urine 311FA non-CF 28.10.2013
Bronchial
swab
5389 non-CF 17.5.2013 Foreskin 320FA non-CF 30.10.2013
Bronchial
swab
5503 non-CF 20.5.2013 Throat swab 11863 non-CF 5.11.2013 throat swab
167FA non-CF 28.5.2013 Bronchialswab 11774
non-
CF 4.11.2013
Bronchial
swab
6227 non-CF 7.6.2013 Throat swab 12049 non-CF 11.11.2013 Throat swab
6607 non-CF 17.6.2013 Throat swab 12144 non-CF 13.11.2013 Throat swab
7339 non-CF 8.7.2013 Throat swab 12572 non-CF 24.11.2013 Throat swab
7491a non-CF 11.7.2013 Sputum 363F non-CF 2.12.2013
Bronchial
swab
7491b non-CF 11.7.2013 Sputum 13029 non-CF 6.12.2013 Tube
223FA non-CF 16.7.2013 Bronchialswab 374F
non-
CF 13.12.2013
Bronchial
swab
13589 non-CF 21.12.2013 Throat swab 3826 CF 9.4.2014 Sputum
13590 non-CF 21.12.2013 Throat swab 195a CF 3.7.2014 Bronchialswab
13620 non-CF 22.12.2013 Throat swab 7316 CF 16.7.2014 Sputum
13761 non-CF 25.12.2013 Sputum 8757 CF 27.8.2014 Sputum
13839 non-CF 27.12.2013 Human milk 8935 CF 1.9.2014 Sputum
13889 non-CF 29.12.2013 Nose swab 9018 CF 3.9.2014 Throat swab
13879 non-CF 28.12.2013 Throat swab 10073 CF 30.9.2014 Throat swab
280H non-CF 22.1.2014 Blood 10454 CF 9.10.2014 Throat swab
2275 non-CF 12.6.2014 Blood 11006 CF 22.10.2014 Sputum
1987 non-CF 19.2.2015 Throat swab 11279 CF 29.10.2014 Throat swab
4584 CF 23.4.2013 Throat swab 11304 CF 29.10.2014 Throat swab
5046 CF 8.5.2013 Throat swab 11382 CF 30.10.2014 Sputum
5310 CF 15.5.2013 Throat swab 11975 CF 12.11.2014 Sputum
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6148 CF 5.6.2013 Throat swab 12606 CF 26.11.2014 Throat swab
6144 CF 5.6.2013 Sputum 12439 CF 23.11.2014 Throat swab
6603 CF 17.6.2013 Sputum 13373 CF 12.12.2014 Sputum
7711 CF 17.7.2013 Sputum 3F CF 5.1.2015 FA
8339 CF 5.8.2013 Sputum 791/15 CF 22.1.2015 Sputum
8687 CF 14.8.2013 Throat swab 1394a CF 4.11.2015 Throat swab
11600 CF 30.10.2013 Throat swab 1394b CF 4.11.2015 Throat swab
12128 CF 13.11.2013 Throat swab 2234 CF 15.2.2015 Sputum
12682 CF 27.11.2013 Throat swab 2483a CF 4.3.2015 Throat swab
13215 CF 12.12.2013 Throat swab 2483b CF 4.3.2015 Throat swab
486/14 CF 15.1.2014 Throat swab 2484 CF 4.3.2015 Sputum
741 CF 22.1.2014 Sputum 3817 CF 8.4.2015 Throat swab
1874 CF 19.2.2014 Throat swab 3944a CF 11.4.2015 Throat swab
2. Media used for bacterial cultivation
S. maltophilia isolate, as well as Pseudomonas aeruginosa PAO1 and
Escherichia coli DH5α were grown in Luria Bertani (LB) liquid medium (Sodium
chloride (0.5%), tryptone (1%) and yeast extract (0.5%)). The solid media for
growth was obtained by the addition of 1.5% agar into LB medium. For the
purpose of testing the sensitivity of antibiotic disc diffusion test and
determining the minimum inhibitory concentration (MIC) with microdilution
test Mueller-Hinton (MH) medium (Oxoid, Hampshire, UK) was used. Motility
assay for swimming, swarming and twitching characteristics was performed in
medium with a low content of the agar. Swimming agar (10 g/l tryptone, 5 g/l
NaCl, 0.3% agar), swarming agar (0.5% agar, 8 g/l nutrient broth, and 5 g/l
glucose), and twitching agar (10 g/l tryptone, 5 g/l yeast extract, 10 g/l NaCl,
1% agar), respectively. Trypticase soy broth (TSB) medium (LabM, UK) was
used in test for biofilm formation. All media were sterilized by autoclaving for
15 min at 121ºC, while bacterial growth was performed at 37°C with aeration.
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3. DNA isolation
Isolation of total DNA from S. maltophilia was made according to the
method described by Hopwood et al., (1985) with appropriate modifications.
The cell precipitate was obtained by centrifugation (2 min, 13000 rpm,
centrifuge 5804, Eppendorf, Hamburg, Germany). Overnight culture, was
washed in 500 µl of TEN buffer (50 mM Tris-HCl, 10 mM EDTA, 50 mM NaCl,
pH 8). Lysis of cells was performed by adding 250 µl of 2% SDS, and gently
rotating the sample, and then the multiple phenolic extraction was done, by
adding 200 µl of the neutral phenol to the samples, with vigorous mixing,
vortexing and centrifugation (10 min, 13000 rpm, centrifuge 5804, Eppendorf,
Hamburg, Germany). The supernatant was carefully collected and transferred
to a new microfuge tube. The precipitation of DNA was made by the addition
of 1/10 volume of 3M Na-acetate and 0.7 volumes of isopropanol, followed by
the centrifuging of samples (20 min, 13,000 rpm, centrifuge 5804, Eppendorf,
Hamburg, Germany). The precipitate was washed by adding 500 µl of 70%
ethanol and centrifugation (10 min, 13000 rpm centrifuge 5804, Eppendorf,
Hamburg, Germany). The obtained precipitate was dried at 37°C, and then the
remaining RNA is eliminated by resuspending the precipitate in 100 µl of
RNase solution (10 mg/mL) in distilled water and allowed to incubate at 37°C
for a period of 15 minutes.
4. Electrophoresis
Electrophoresis of total DNA as well as fragments obtained by the PCR
was performed in a 1% agarose gel. The gels were made by dissolving the
agarose in 1X TAE buffer (40 mM Tris-acetate, 2 mM EDTA and final pH 8.0)
with the addition of ethidium bromide (0.5 mg/ml). Electrophoresis was run in
1X TAE buffer at a constant voltage of 1-10 V per cm of the gel. Sizes of
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analyzed fragments were determined by comparing the length of obtained
fragments with DNA fragments of standard, "GeneRulerTM 1 kb DNA Ladder
Mix" (Thermo Scientific, Fermentas, Lithuania).
5. Molecular identification and genotyping
of clinical isolates
5.1. Polymerase Chain Reaction (PCR) analysis of 16S rRNA gene
Laboratory identification of the isolates was carried out using standard
biochemical testing and automated Vitek 2 system (BioMérieux, Marcy l'Etoile,
France). Molecular identification of the strain was performed by PCR analysis
of 16S rRNA gene with specific primers UNI16SF and UNI16SR (Table 2). PCR
products were purified with GeneJET PCR Purification Kit (Thermo Scientific,
Lithuania) and sequenced by the Macrogen DNA sequencing service (Macrogen
Inc., Netherlands). Obtained sequences were aligned in the NCBI database by
using BLAST program.
Table 2 – Specific primers used in this study.
Name of
the primer Sequence of the primer
Annealing
Temperatures References
UNI16SF 5-GAG AGT TTG ATC CTG GC-3 50°C Jovcic et al., 2009
UNI16SR 5-AGG AGG TGA TCC AGC CG-3 50°C Jovcic et al., 2009
atpD forw 5-ATGAGTCAGGGCAAGATCGTTC-3 62°C MLST Data base
atpD rev 5-TCCTGCAGGACGCCCATTTC-3 62°C MLST Data base
gapA forw 5-TGGCAATCAAGGTTGGTATCAAC-3 62°C MLST Data base
gapA rev 5-TTCGCTCTGTGCCTTCACTTC-3 62ºC MLST Data base
gapA
forw(2fwd) 5-AGGAGCTTGAGAAATGGCAA-3 48-58°C MLST Data base
gapA
rev(2r) 5-GAGTAGCCCCACTCGTTGTC-3 48-58°C MLST Data base
guaA forw 5-AACGAAGAAAAGCGCTGGTA-3 62°C MLST Data base
guaA rev 5-ACGGATGGCGGTAGACCAT-3 62°C MLST Data base
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mutM forw 5-AACTGCCCGAAGTCGAAAC-3 58,62°C MLST Data base
mutM
rev(2r) 5-GAGGATCTCCTTCACCGCATC-3 58,62ºC MLST Data base
mutM
rev(4r) 5-TTACCGGCCTCGCGCAG-3 52,48°C MLST Data base
nuoD forw 5-TTCGCAACTACACCATGAAC-3 48°C MLST Data base
nuoD rev 5-CAGCGCGACTCCTTGTACTT-3 48°C MLST Data base
nuoD
forw(2f) 5-AGGAAATCCGCAACTACACC-3 48°C MLST Data base
nuoD
rev(2r) 5-AGCGCGACTCCTTGTACTTC-3 48°C MLST Data base
ppsA forw 5-CAAGGCGATCCGCATGGTGTATTC-3 62°C MLST Data base
ppsA rev 5-CCTTCGTAGATGAA(A/G)CCGGT(A/G)TC-3 62°C MLST Data base
ppsA
forw(2f) 5-TTCACCCTGGACACCGAGT-3 58°C MLST Data base
ppsA
rev(2r) 5-CGAAGTCGAAGGCACGTT-3 58°C MLST Data base
recA forw 5-ATGGACGAGAACAAGAAGCGC-3 62°C MLST Data base
recA REV 5-GGTGATGACCTGCTTGAACGG-3 62°C MLST Data base
MutM_10f 5-CTGCCCGAAGTCGAAACAA-3 58°C MLST Data base
mutM_803r 5-CAGTGGCTGCACCAGACG-3 58°C MLST Data base
mutM_11f 5-TGCCCGAAGTCGAAACCAC-3 58°C MLST Data base
mutM_804r 5-GCAGTGGCTGCACCAGAC-3 58°C MLST Data base
mutM_13f 5-CCCGAAGTCGAAACCACCC-3 58°C MLST Data base
mutM_802r 5-AGTGGCTGCACCAGACG-3 58°C MLST Data base
mutM_14f 5-CCGAAGTCGAAACCACCCG-3 58°C MLST Data base
mutM_800r 5-TGGCTGCACCAGACGC-3 58°C MLST Data base
rmlA 5-GCAAGGTCATCGACCTGG-3 60°C Pompilio et al. 2011
rmlA 5-TTGCCGTCGTAGAAGTACAGG-3 60°C Pompilio et al. 2011
spgM 5-GCTTCATCGAGGGCTACTACC-3 60°C Pompilio et al. 2011
spgM 5-ATGCACGATCTTGCCGC-3 60°C Pompilio et al. 2011
rpfF 5-CTGGTCGACATCGTGGTG-3 60°C Pompilio et al. 2011
rpfF 5-TGATCCGCATCATTTCATGC-3 60°C Pompilio et al. 2011
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PCR amplification was performed by mixing of total DNA (0.1-1 µg)
with 1X reaction buffer (standard reaction buffer 10X with Mg2+, Kapa
biosystems, USA), a mixture of dNTPs (each dNTP in final concentration of 200
µM), primers (each 2.5 µM) and Taq DNA polymerase (1 U/µl, Kapa
biosystems, USA). PCR reactions were performed using GeneAmp 2700 PCR
Cycler "(Applied Biosystems, USA) according to the programme in Table 3.
Table 3 - PCR reaction for 16S rRNA gene amplification.
Reaction phase Temperature Time Number of cycle
Initiation denaturation 94°C 5 min
Denaturation 94°C 30 s
Hybridization (annealing) 50°C 30 s
Elongation 72°C 30 s
30 cycles
Final elongation 72°C 10 min
5.2. Pulsed Field Gel Electrophoresis (PFGE)
PFGE was performed as previously described (Kojic et al., 2005) and for
this analysis XbaI enzyme (Thermo Scientific, Lithuania) was used, and
obtained profiles were subject of statistical analysis. In situ preparation of
samples for PFGE was performed as follows. Cells grown in LB broth at 37°C to
early logarithmic phase and collected by centrifugation (13000 rpm for 5 min).
The collected cells were washed twice with EET buffer (100 mmol/l EDTA, 10
mmol/l EGTA, 10 mmol/l Tris-HCI, pH 8.0) and resuspended in 50 µl of the
same buffer to obtain 109 cells/ml. This cell suspension was warmed on water
bath at 42°C and mixed with an equal volume of prewarmed gel (0.1% mlv
agarose (InCertTM Agarose, Lonza, Rockland, MA, USA) in 5 ml of EET buffer),
poured in 100 µl block modules, and allowed to solidify at 4°C. The agarose
blocks with incorporated cells were then incubated overnight at water bath
50°C in 500µl of EET buffer with SDS (0.5 % mlv) and proteinase K (0.5 mg/ml)
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with gentle shaking. Final treatment of agarose blocks constituted of washing
two times in 100 volumes of TE buffer (10 mmol/l Tris-HCI, 1 mmol/l EDTA,
pH 8.0) or water containing 0.1 mmol/l PMSF (phenylmethylsulfonyl fluoride)
and two times in water, each time for 30 min at room temperature with slowly
shaking. Prepared agarose blocks were sliced, and each slice was preincubated
for 30 min in 500 µL of the XbaI restricting enzyme buffer at room temperature.
After that, the buffer was removed and replaced with fresh buffer (100 µl)
containing 20 units per blocks, of the XbaI restriction enzyme. Digestion was
carried out for 3 h at 37°C. The reaction was stopped by adding a stop solution
buffer (40% sucrose, 10 mmol/l EDTA, 0.01% bromophenol blue, pH 8.0) and
samples were kept at 4°C before use.
PFGE was performed with a 2015 Pulsafor unit (LKB Instruments,
Broma, Sweden) equipped with a hexagonal electrode array. Electrophoresis.
Agarose gels (1.2% m/ v) were run in 0.5x TBE running buffer (45 mmol/l Tris,
45 mmol/l boric acid, 1 mmol/l EDTA, pH 8.3) for 18 h at 300 V at 9°C. Pulse
times were increased by step from 8s first 8 h to 18s additional 10 h, during
electrophoresis. The gels were stained with 30µl ethidium bromide for 30 min
with shaking at room temperature, then washed with 0.5x TBE buffer for 30
min with shaking at room temperature, and photographed under UV
illumination. Lambda phage concatemers (Biolabs, England) were used as
molecular size markers.
5.3. Multilocus sequencing typing (MLST) analysis
MLST was performed as was described in Kaiser et al (2009) and the
primers and protocols were downloaded from the website of the S. maltophilia
MLST database (http://pubmlst.ors/smaltophilia/). MLST was performed by
PCR amplification and sequencing of seven housekeeping genes: atpD (H(+)-
transporting two-sector ATPase), gapA (NAD-dependent glyceraldehyde-3-
phosphate dehydrogenase), guaA (GMP synthase), mutM (DNA-
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formamidopyrimidine glycosylase), nuoD (NADH dehydrogenase), ppsA
(pyruvate, water dikinase), recA (RecA protein). Sequences of the primers are
given in the Table 2. The PCR amplification was performed as described
previously with addition of 1µl of Dimethyl sulfoxide (DMSO). PCR reactions
were performed using GeneAmp 2700 PCR Cycler "(Applied Biosystems, USA)
according to the programmes given in the Table 4. Allele profiles obtained after
sequencing were used to determine specific sequence type (ST) for analyzed
isolates using MLST Database at the University of Freiburg, Germany.
Table 4 - PCR reaction for MLST analysis.
Reaction phase Temperature Time Number ofcycle
Initiation denaturation 95°C 9 min
Denaturation 94°C 20 s
Hybridization (annealing) Recommended temperature 1 min
Elongation 72°C 50 s
Final elongation 72°C 5 min
30 cycles
Exception for amplification of mutM gene
Initial denaturation 95°C 9 min
Denaturation 94°C 40 s 35 cycles
Hybridization (annealing) 58°C 40 s
Elongation 72°C 1 min
Final elongation 72°C 7 min
6. Antimicrobial susceptibility testing
6.1. Disc diffusion methode
The sensitivity of the isolates to the following antibiotics was done using
the disc diffusion method: tetracycline (30 μg), chloramphenicol (30 mg),
livofloxacin (5 μg) and ciprofloxacin (5 μg). Commercial antibiotic discs were
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used (Bio Rad, Marnes-la-Coquette, France) and interpretation of obtained
results for inhibition zone according to CLSI, 2015. When specific critere for S.
maltophilia were not present, relevant criteria for Pseudomonas aeruginosa or non-
Enterobacteriaceae were used.
Table 5 – Determination of the results obtained with disc diffusion method.
MIC (µg/ml)Antibiotic disc S I R
Tetracycline 30µg/ml ≥15 12-14 ≤11
Chloramphenicol 30µg/ml ≥18 13-17 ≤12
Ciprofloxacin 5µg/ml ≥21 16-20 ≤15
Levofloxacin 5µg/ml ≥17 14-16 ≤13
For this purpose all tests were performed in Mueller-Hinton broth
(Oxoid, UK) and suspension of eash isolate was adjusted to the density of 0.5
McFarland (Biosan, Latvia). Cell density was measured at OD600 in a microtitre
plate reader (Tecan, Austria GmbH) after 24 h of incubation at 37°C. Prepared
bacterial suspension was swabbed carfully on a thin layer of Muller Hinton
agar to cover entire agar sarface in Petrie dishes. Antibiotic discs were placed
on the surface of the agar, then the dishes were incubated overnight at 37°C.
The diameter of the inhibition zone formed around antibiotic disc was
measured.
6.2. Microdilution method
Antimicrobial susceptibility testing by using microdilution method was
performed for trimethoprim–sulfamethoxazole (TMP/SMX) in order to
determine Minimal inhibitory concentration (MIC). For this purpose all test
were performed in Mueller-Hinton broth (Oxoid, UK) and TMP/SMX
concentrations were 2, 4, 8, 16, 32 and 64 μl/ml, according to the criteria of the
Clinical and Laboratory Standards Institute – CLSI (CLSI, 2015) guidelines.
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When specific critere for S. maltophilia were not present, relevant criteria for
Pseudomonas aeruginosa or non-Enterobacteriaceae were used. First step in this test
was preparation of the strains: A single colony of bacteria grown on LB agar
were added to 5ml of MH broth, and the suspension of each isolate was
adjusted to the density of 0.5 McFarland (Biosan, Latvia). Second step was
preparation of antibiotic stock solution trimthoprim was mixed with
sulfamethoxazole ratio 1:19 respectivly. Different antibiotic concentration were
mixed with bacterial cells suspension and added to the wells, the control wells
were one for the antibiotic, one for strains suspension, and one for MH media.
Cell density was measured at OD600 in a microtitre plate reader (Tecan, Austria
GmbH) after 24 h of incubation at 37°C. All experiments were performed in
triplicate. Microsoft Excel software was used for the calculation of the MIC50
and MIC90 (the concentration of antimicrobial agents which inhibited the
growth rate by 50% and 90%, respectively) values. Obtained values for MIC50
and MIC90 are the results of three independent experiments.
7. Surface characteristics and motillity assay
Surface characteristics were determined as described previously (Begovic
et al., 2010). The cells from overnight culture in LB media were collected by
centrifuge 1ml of overnight culture for 5min 13000 rpm, discard the supernatant
and the cells were washed in 1ml of potassium phosphate buffer (0.1M, PH 7)
centrifuged 5min, 13000 rpm, discard the supernatant and resuspended the cells
with 500µl of the same 0.1M potassium phosphate buffer, vortex. on a glass
tube we put 4ml of potassium phosphate buffer and the previously prepared
suspension of bacterial cell with the buffer were add to this glass tube slowly,
vortx and measure the OD600 of the cells on spectrophotometer (Ultrospec 3300
Pro, Amersham Biosciences) to get OD=1, then the organic solution Hexadecane
150µl was added to 3ml of prepared bacterial suspension, the mixture was
MATERIALS AND METHODS
41
vortexed twice for 30s with 30s intermissions between vortexing,  then 1ml of
the lower phase was thaken and transferred to cuvitt after vortexing, the OD600
of the lower phase and the bacterial suspension before mixing with hexadecane
were measured. Microbial adhesion to hexadecane (MATH) was analyzed for
all strains. The optical density of the initial OD0 (OD of cell and buffer mixture)
and extracted solution OD1 (OD of cells suspension and hexadecane) was
measured at OD600 (Ultrospec 3300 Pro, Amersham Biosciences). According to
this equation: θ = OD0 – OD1/OD0 the fraction of bacteria adhering to
hexadecane/water interface was calculated. To determine strain
hydrophobicity previously defined values were used as reference values: 0-35%
low hydrophobicity, 36-70% medium hydrophobicity and 71-100% high
hydrophobicity. Microbial adhesion to hexadecane (MATH) was analyzed for
all 88 strains.
Motillity assay for swimming, swarming and twitching characteristics
were performed as described previously (Pompilio et al., 2011). A single colony
from an overnight agar growth was inoculated onto swimming and swarming
agar while for twitching agar, a single colony was inoculated at the bottom of a
Petri dish containing twitching agar. After incubation at 37°C for 24 h, results
were expressed as the diameter (mm) of the area observed at the agar surface.
8. Mucin binding assay
Ability of S. maltophilia strains to bind to mucin was tested as it was
previously described (Muñoz-Provencio et al., 2009) with some
modification. Briefly, flat-bottomed polystyrene 96-well plate (Sarsted,
Newton, USA) were covered with the mucin (porcine stomach, Sigma,
Germany), 30 mg/ml of mucin in 50 mM of carbonate buffer pH 9.6, while
control plates were filled with the same volume of 50 mM carbonate buffer (200
µl). Plates were incubated overnight at 4°C. After immobilization, plates were
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washed three times with 1X PBS and blocked at room temperature for 1 h with
PBS plus 1% Tween 20 to saturate the uncoated binding places. After washing
the plates again three times with 200µl of 1X PBS, 200 µl (20µl of overnight
culture plus 180µl of 1X PBS) of bacterial suspension adjusted to the density of
0.5 McFarland were added and plates were incubated 2h at 37°C. Non-adhered
cells were removed by washing three times with 1X PBS containing 0.05%
Tween 20 and the plates were dried at 65°C. Adhered cells were stained with
0.1 mg/ml of crystal violet (200µl/well) incubated for 45 min at room
temperature. Dye was discarded, plates were dried on 65º C and the unbound
stain were removed by washing three times with1X PBS. For dissolving the
stain bounded to the bacterial cell 50 mM of citrate buffer pH 4.0 (200 µl/well)
were added and incubated for 1h at room temperature and the absorbance was
measured at 595 nm.
9. Biofilm formation assay
Biofilm formation assay was performed as described previously
(Stepanović et al., 2007). Over night cultures of S. maltophilia isolates in 3 ml of
Trypticase soy broth (TSB) (oxoid) were washed and diluted in fresh TSB and
standardized to contain 1 x 105 to 1 x 106 CFU/ml. Suspension of each isolate
was adjusted to the density of 0.5 McFarland (Biosan, Latvia). The cultures were
then diluted 1 : 100 in 200 µl tryptic soy broth (TSB) and then 200 µl of each
strains were inoculated into the wells of a flat-bottomed polystyrene 96-well
plate (Sarsted, Newton, USA). As positive control we used Pseudomonas
aeruginosa PAO1, while negative control was Escherichia coli DH5α, and TSB
without bacteria was the control of all test. Incubation was performed at 37°C
for 24h, then plates were washed three times with 200µl of 1X sterile phosphate
buffered saline PBS (pH 7.2). Adherent biofilms were fixed for 30 min at 65°C,
the plate were stained for 30 min at room temperature with 160 µl of 0.01%
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crystal violet (HI Media). Dye was discarded and the plates were dried at 65ºC
and then washed three times with 1X PBS and dried again at 65°C. Biofilm
samples were destained with 200 µl of solution containing 96% ethanol and
aceton in ration 4:1 for 15 min and the optical density OD was read at 595 nm.
The low cut-off (ODc) was calculated as the three standard deviations 3 x SD
above the mean OD of control wells. Classification of strains were performed
acording to the following criteria: no biofilm producer (OD ≤ ODc), weak
biofilm producer (ODc ˂ OD ≤ 2 x ODc), moderate biofilm producer (2 x ODc ˂
OD ≤ 4 x ODc) and strong biofilm producer (4 x ODc ˂ OD).
9.1. PCR based genotyping for rmlA, spgM, and rpfF genes
PCR with specific primers for rmlA, spgM, rpfF were performed as
described previously by (Pompilio et al., 2011). The PCR amplification was
performed as described previously (section 5. Molecular identification of
clinical isolates). Sequences of the primers are given in the Table 2. PCR
reactions were performed using GeneAmp 2700 PCR Cycler "(Applied
Biosystems, USA) according to the programme given in the Table 6.
Table 6 - PCR reaction for rmlA, spgM, rpfF genes amplification.
Reaction phase Temperature Time Number of cycle
Initiation denaturation 94°C 5 min
Denaturation 94°C 30 s
Hybridization (annealing) 60°C 30 s
Elongation 72°C 30 s
30 cycles
Final elongation 72°C 10 min
PCR products were sequenced by the Macrogen DNA sequencing service
(Macrogen Inc., Netherlands). Obtained sequences were aligned in the NCBI
database by using BLAST program.
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9.2. Kinetics of the biofilm formation
Kinetics of the biofilm formation was performed for seven strong biofilm
producer strains. Overnight cultures of S. maltophilia in Trypticase soy broth
(TSB) (Oxoid) were washed, diluted with fresh TSB, and standardized to
contain 5 x 105 to 1 x 106 CFU/ml. Aliquots (200 µl) of standardized inoculum
were added to the wells of sterile flat-bottom polystyrene 96 wells plates
(Sarsted, Newton, USA), and incubated at 37°C. After incubation for 30 min, 1,
2, 4, 8, and 24 h plates were treated like it was described under subtitle Biofilm
formation assay and biofilm formation was determined.
10. Infeluence of different factors on biofilm formation
by S. maltophilia.
Influence of different factors on biofilm formation by S. maltophilia strais
which, formed strong, moderate and week biofilm was determined. Biofilm
formation assay were done as descibed above. Briefly, overnight cultures of S.
maltophilia, prepared in TSB broth (Oxoid) were washed twice, and diluted with
fresh TSB , and standardized to contain (1x 105  or 106 CFU/mL). Aliquots (200
µL) of standardized inoculum were added to the wells of sterile flat-bottom
polystyrene 96 wells plates, and incubation was performed in different
conditions: pH 5.5 and 8.5, temperature (cold shock 12°C, 30°C, 37°C and heat
chock 45°C), 10% saturation with CO2 (Heracell 150, Thermo Fischer Scientific
Inc., Walthman, MA, USA), dynamic conditions (with agitation). The biofilm
formation was evaluated as described above in Biofilm formation assay
paragraph. All experiments were performed in three independent repetitions.
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10.1. Effect of TMP/SMX on S. maltophilia formed biofilm
Biofilm formation by S. maltophilia was preformed in flat-bottomed
polystyrene 96-well plates (Sarsted, Newton, USA) as described above (biofilm
formation assay). After 24h incubation at 37ºC, the supernatant from each well
was gently aspirated by micropipette, each well was then washed three times
with 200µl of 1X PBS, and 200µl of antimicrobial agents at two different
concentrations (25 and 50µg/ml) was added to the wells. Controls were the
formed biofilm by the strains without adding the antimicrobial agent. The
plates were incubated at 37ºC for 6h, after incubation the supernatant was
discared and plates were washed three times with 200µl of 1X PBS, dried on
65ºC for 30min, and dyed with 0.01% crystal violet for 30 min at room
temperture. Biofilm formation assay was performed as described previously.
11. Statistical analysis
Statistical analyses was performed using the SPSS 20.0 statistical
software package (IBM Corporation). Jaccard coefficient was used for
calculation of similarity matrix to determine similarity coefficients. Two-tailed
Mann-Whithey test was used to describe differences between the groups.
Calculation of Spearmann's rho coefficient was used for correlations analysis.
In addition, some statistical analysis was performed with the Phoretix 1D
Pro (TotalLab, free trial license) program with 1% tolerance, while for
dendrogram creation Band difference and Complete Linkage algorithm
(Defays, 1977) were used. Heatmaps and cluster analysis was performed using
R packages gtools, hclust and gplots. To determine the statistical differences
between the groups t test was used.
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12. Ethics Statement
The authors assert that all procedures contributing to this work comply
with the ethical standards of the Ethics Committee of The Institute for Mother
and Child Health Care of Serbia “Dr Vukan Čupić“ on human experimentation
and with the Helsinki Declaration of 1975, as revised in 2008. Since the analysis
was performed retrospectively on isolates collected through routine clinical
work and patient identifiable information was anonymized, no written or
verbal informed consent to participate in this study from patient was necessary.
The authors had no contact or interaction with the patients. Patient
demographics anonymization was performed in two steps. First, personal data
was coded by the head of the clinical microbiology laboratory at the Institute
for Mother and Child Health Care “Dr Vukan Čupić” where the isolates were
obtained from, and secondly by assigning a different code by the principal
investigator at the Institute of Molecular Genetics and Genetic Engineering
where the molecular analysis was conducted. Ethics Committee of The Institute
for Mother and Child Health Care of Serbia “Dr Vukan Čupić“ specifically
approved this study, approval No. 8/6a.
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4. RESULTS 
1. Clinical population and Strenotrophomonas maltophilia 
isolation 
Sixty-eight patients from tertiary care pediatric hospital Institute for 
Mother and Child Health Care “Dr Vukan Čupić„ were included in the study, 
32 males and 36 females. The median age of the patients was 0.7 years (range 3 
days to 34 years). There were 27 CF patients that were treated as outpatients 
and inpatients. Out of 41 non-CF patients, 27 (65.9%) were hospitalized in three 
intensive care units (pediatric medical, surgical and cardiothoracic), while the 
remaining 14 were treated on different specialized clinical wards. A total of 88 
clinical isolates from 68 patients were examined (Table 1). The 42 isolates from 
27 CF patients were cultured from sputum samples (n=16), cough swabs (n=24) 
and bronchial washing fluid (n=2). The 46 isolates from non-CF patients were 
cultured from a number of sites, including blood (n=2), bronchial washing fluid 
(n=8), endotracheal aspirate (n=24), sputum (n=3), urine (n=1), abdominal 
cavity drainage fluid (n=1), cough swab (n=2), breast milk (n=1), nose/throat 
secretions (n=3) and wound (n=1). Single isolates were archived from each of 52 
patients (16 CF and 36 non-CF) while from 16 additional patients (11 CF and 5 
non-CF) more than one isolate were collected per patient. 
2. Identification of S. maltophilia clinical isolates 
Initial laboratory identification of the isolates was carried out using 
standard biochemical testing and automated Vitek 2 system (BioMérieux, 
Marcy l'Etoile, France). Molecular identification of the strain was performed by 
sequencing of PCR products of amplified 16S rRNA gene which, confirmed that 
all analyzed clinical isolates belong to S. maltophilia species with identity 
ranging from 95% to 99% with S. maltophilia strains from the NCBI database. 
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3. Genotyping of S. maltophilia clinical isolates 
To determine genetic relatedness among the analyzed isolates PFGE 
analysis was performed. Obtained PFGE profiles are presented at the Figure 1. 
Immense diversity among PFGE profiles was observed and 11 different 
pulsotype was observed. 
 
Figure 1. PFGE profiles for S. maltophilia clinical strains. L – λ concatemeres 
standard. Names of the strains are presented with numbers on the gels. 
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PFGE revealed that most of the strains do not show significant genetic 
relatedness among themselves. Based on the diversity of genetic profiles 
obtained, dendrogram that reconstruct phylogenetic relationships within 
collection was constructed using Complete linkage and is shown in Figure 2.  
 
Figure 2. Phylogenetic analysis of obtained PFGE XbaI profiles. Genetic 
relatedness between the analyzed strains are shown above the dendrogram 
with the distance. Names of the strains are indicated with the numbers on the 
right side. Results of MLST analysis, CF origin – C, non-CF origin – N, source of 
isolation, biofilm formation, gender of the patients, rmlA, spgM and rpfF gene 
amplification for each strain are presented in the table on the right side. 
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Based on the PFGE results 11 pulsotypes were determined and selected 
for MLST analysis which, showed that six sequence types (ST) were novel 
(Table 7). Three isolates (11600, 10668 and 12682), belong to ST31, a sequence 
type isolated in Perth, Australia. One isolate, 7491b, belongs to group ST4, in 
which there are two other isolates from Europe, while other are novel. These 
previously identified STs are also clinical isolates of human origin. Sequences 
are deposited at the MLST Database at the University of Freiburg, Germany, 
http://pubmlst.org/perl/bigsdb/bigsdb.pl?db=pubmlst_smaltophilia 
isolates&page=query. 
 
Table 7. Sequence type (ST) of 11 S. maltophilia clinical isolates. 
Strain atpD gapA guaA mutM nuoD ppsA recA ST 
11600 allele 3 allele 4 allele 24 allele 7 allele 7 allele 22 allele 7 31 
7491b allele 1 allele 4 allele 7 allele 7 allele 28 allele 19 allele 6 4 
10668 allele 3 allele 4 allele 24 allele 7 allele 7 allele 22 allele 7 31 
12682 allele 3 allele 4 allele 24 allele 7 allele 7 allele 22 allele 7 31 
6603 allele 3 allele 4 allele 18 allele 1 allele 7 allele 20 allele 1 114 
7711 allele 3 allele 4 allele 18 allele 1 allele 7 allele 20 allele 1 114 
11774 allele 3 allele 1 allele 84 allele 57 allele 25 allele 82 allele 6 115 
4477 allele 3 allele 1 allele 84 allele 58 allele 25 allele 82 allele 6 116 
6227 allele 1 allele 4 allele 43 allele 3 allele 70 allele 83 allele 7 117 
8757 allele 2 allele 2 allele 93 allele 59 allele 63 allele 69 allele 5 118 
13215 allele 4 allele 76 allele 92 allele 5 allele 70 allele 84 allele 9 119 
 
4. Antibiotic susceptibility of S. maltophilia clinical isolates 
Trimethoprim–sulfamethoxazole (TMP/SMX) demonstrated excellent 
inhibitory effect against all of the S. maltophilia tested, which confirmed its 
potential in clinical treatment. For all tested isolates, the MIC50 was ≤4 µg/ml, 
while the MIC90 was ≤32 µg/ml. Furthermore, the MIC90 was ≤10 µg/ml for 60 
of the all 88 analyzed strains (68.18%). Additionally, we performed analyses by 
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disk diffusion methods with a few selected antibiotics. All of the tested strains 
were sensitive to all tested antibiotics, (Table 8). 
Table 8. Antibiotic susceptibility of the S. maltophilia clinical isolates (n=88) 
obtained with two different methods. 
 Disc diffusion method  
Antimicrobial agents Zone diameter interpretative Percentage of susceptibility strains 
 S I R  
Ciprofloxacin** ≥ 21 16-20 ≤ 15 100% 
Chloramphenicol* ≥ 18 13-17 ≤ 12 100% 
Tetracycline** ≥ 15 12-14 ≤ 11 100% 
Levofloxacin ≥ 17 14-16 ≤ 13 100% 
 Microdilution method  
 S I R  
TMP/SMX ≤ 2/38 - ≥ 4/76 100% 
* - breakpoints for E. coli ATCC25922, ** - breakpoints for P. aeruginosa ATCC27853 
TMP/SMX – trimethoprim/sulfomethoxazole 
5. Virulence factors analysis 
5.1. Motility, surface characteristics and adhesion to mucin 
of S. maltophilia clinical isolates 
Different types of motility swimming, swarming and twitching 
characteristics were analyzed in S. maltophilia clinical isolates. Interestingly, 
swimming motility was observed in all tested strains, while none of the tested 
strains showed swarming or twitching motility. Zones detected for swimming 
motility were in the range from 0.5 to 5 cm. 
On the contrary, out of 88 analyzed strains, only one strain adhered to 
hexadecane (44% adherence) which classified it as a strain 13590 with medium 
hydrophobicity of the cell surface, while all other strains had low percentages of 
adherence to this non-polar solvent, indicating low hydrophobicity of their cell 
surfaces. 
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Ability of clinical isolates to adhere to mucin was calculated as the ratio 
of absorbance at 595 nm, measured in mucin-coated wells against absorbance in 
control non-coated wells. There were no differences in mucin-adhesion ability 
between CF and non-CF isolates. Aside from comparing mucin-binding ability 
of CF and non-CF isolates, the ability of each individual strain to adhere to 
mucin was compared to its affinity to adhere to a plastic surface (mucin-coated 
vs. non-coated wells) (Figure 3). Mann-Whitney test revealed significantly 
higher adhesion of the isolates to mucin-coated compared to adhesion to non-
coated wells (p<0.05). 
 
 
Figure 3. Adhesion of bacterial isolated to mucin-coated and non-coated wells 
of microtiter plate. Bars represent mean values ± standard errors. 
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5.2. Biofilm formation of S. maltophilia clinical isolates 
 
Figure 4. Biofilm formed by individual bacterial S. maltophilia strains 
isolated from CF and non-CF patients 
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Ability to form biofilm was detected in the most of the analyzed strains 
with almost equal representation in CF and non-CF strains (Figure 4). Biofilm 
formation assay was performed on polystyrene plates and results were strong 
biofilm was formed by seven strains (7.95%), only nine strains (10.2%) did not 
form biofilm, moderate biofilm was formed by 37 strains (42.05%), while weak 
biofilm was formed by 35 strains (39.8%) (Figure 5). From the seven strains 
forming strong biofilm four were from CF patients (9.5% vs. 6.5%), but among 
the 37 strains that formed moderate biofilm slight majority were from non-CF 
patients (45.7% vs. 38.1%). 
Moderate
Strong
Weak
No
39.8%
7.95%
10.2%
42.05%
 
Figure 5. Percent of different biofilms formed by S. maltophilia strains 
Source of strain isolation did not affect biofilm formation, except for 
strong biofilm producers, since all were respiratory isolates except one from 
blood culture. According to PCR – based analysis, rmlA, rpfF and spgM genes 
were present in 86 strains (97.7%), 62 strains (70.4%) and 63 strains (71.6%), 
respectively (Figure 2). There was no difference in the presence of the analyzed 
genes between CF and non-CF patients. Spearmann’s rho coefficients (Table 9) 
showed that there was no statistical correlation between biofilm strength and 
the presence of rmlA, rpfF or spgM genes (presence of the signal was marked as 
1 and absence as 0). Nevertheless, the presence of both rpfF and spgM genes in 
one strain was correlated with strong biofilm formation (p<0.05), while there 
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was no correlation in other gene combinations (rmlA + rpfF and rmlA + spgM). 
Moreover, a negative correlation was observed between rpfF and spgM presence 
(p<0.05). 
Table 9. Correlations between presence of PCR signals for spgM, rpfF and 
rmlA genes and biofilm formation in bacterial isolates according to 
Spearmann’s rho coefficients. 
Presence of 
strong biofilm
Presence of 
spgM gene
Presence of 
rpfF gene
Presence of 
rmlA gene
Sum of 
presence of 
spgM and rpfF 
genes
Sum of 
presence of 
rpfF and rplA 
genes
Sum of 
presence of 
spgM and rplA 
genes
Correlation Coefficient 1.000 .143 .149 .048 .233
* .160 .155
Sig. (2-tailed) .183 .166 .655 .029 .136 .150
N 88 88 88 88 88 88 88
Correlation Coefficient .143 1.000 -.214
* -.069 .615
**
-.230
*
.926
**
Sig. (2-tailed) .183 .046 .522 .000 .031 .000
N 88 88 88 88 88 88 88
Correlation Coefficient .149 -.214
* 1.000 -.072 .639
**
.930
**
-.231
*
Sig. (2-tailed) .166 .046 .506 .000 .000 .031
N 88 88 88 88 88 88 88
Correlation Coefficient .048 -.069 -.072 1.000 -.112 .301
**
.312
**
Sig. (2-tailed) .655 .522 .506 .297 .004 .003
N 88 88 88 88 88 88 88
Correlation Coefficient .233
*
.615
**
.639
** -.112 1.000 .570
**
.543
**
Sig. (2-tailed) .029 .000 .000 .297 .000 .000
N 88 88 88 88 88 88 88
Correlation Coefficient .160 -.230
*
.930
**
.301
**
.570
** 1.000 -.105
Sig. (2-tailed) .136 .031 .000 .004 .000 .328
N 88 88 88 88 88 88 88
Correlation Coefficient .155 .926
**
-.231
*
.312
**
.543
** -.105 1.000
Sig. (2-tailed) .150 .000 .031 .003 .000 .328
N 88 88 88 88 88 88 88
*. Correlation is significant at the 0.05 level (2-tailed).
**. Correlation is significant at the 0.01 level (2-tailed).
Correlations
Spearman's rho
Presence of strong biofilm
Presence of spgM gene
Presence of rpfF gene
Presence of rmlA gene
Sum of presence of spgM 
and rpfF genes
Sum of presence of rpfF 
and rplA genes
Sum of presence of spgM 
and rplA genes
 
However, according to Mann-Whitney test, non-CF isolates showed 
higher biofilm forming potential and motility than CF isolates (p = 0.021 and p 
= 0.0001) (Fig 6A and 6B).  
  
Figure 6. Biofilm forming potential (A) and motility (B) of non-CF and CF 
bacterial isolates. Bars represent mean values ± standard errors. 
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In addition, the same trend in changing motility and strength of biofilm 
formation was observed (Figure 7). Strains forming stronger biofilm show high 
motility with no statistically important differences in motility between CF and 
non-CF isolates forming strong biofilm (p = 0.78). 
 
Figure 7. Correlation between the strength of formed biofilm and motility of 
S. maltophilia strains isolated from CF and non-CF patients. 
 
Spearmann’s rho coefficients were calculated to check for correlations 
between three tested parameters (mucin adhesion, motility and biofilm 
formation) and results were that motility has shown positive correlations (p < 
0.01) with both biofilm formation and the mucin-adhesion ability of the strains 
(Table 10).  
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Table 10. Correlations between tested physiological parameters of bacterial 
isolates according to Spearmann’s rho coefficients. 
Biofilm formed by 
bacterial isolates 
(absorbance at 595 
nm)
Motility of 
bacterial 
isolates (mm)
Mucin binding ability of bacterial 
isolates (adhesion in mucin-
coated wells relative to 
adhesion in control wells)
Adhesion of bacterial 
isolates to mucin-coated 
wells
Adhesion of bacterial 
isolates to empty wells
Correlation Coefficient 1.000 .398
** .170 .033 .013
Sig. (2-tailed) .000 .113 .762 .908
N 88 88 88 88 88
Correlation Coefficient .398
** 1.000 .307
**
.270
*
.244
*
Sig. (2-tailed) .000 .004 .011 .022
N 88 88 88 88 88
Correlation Coefficient .170 .307
** 1.000 .669
**
.461
**
Sig. (2-tailed) .113 .004 .000 .000
N 88 88 175 88 88
Correlation Coefficient .033 .270
*
.669
** 1.000 .944
**
Sig. (2-tailed) .762 .011 .000 .000
N 88 88 88 88 88
Correlation Coefficient .013 .244
*
.461
**
.944
** 1.000
Sig. (2-tailed) .908 .022 .000 .000
N 88 88 88 88 88
**. Correlation is significant at the 0.01 level (2-tailed).
*. Correlation is significant at the 0.05 level (2-tailed).
Correlations
Spearman's rho
Biofilm formed by bacterial 
isolates (absorbance at 
595 nm)
Motility of bacterial 
isolates (mm)
Mucin binding ability of 
bacterial isolates 
(adhesion in mucin-coated 
wells relative to adhesion 
in control wells)
Adhesion of bacterial 
isolates to mucin-coated 
wells
Adhesion of bacterial 
isolates to empty wells
 
5.2.1. Kinetics of strong biofilm formation 
Kinetics of biofilm formation was determined for selected strains (Figure 
8) which showed that non-CF isolates formed biofilm faster than CF isolates.  
 
Figure 8. Kinetics of the biofilm formation by selected S. maltophilia strains 
isolated from CF and non-CF patients. Biofilm strength was designated from 0 
to 3 where 3 is strong, 2 is moderate, 1 is weak, and 0 is no biofilm. 
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Although, they were all strong biofilm producer biofilm formation 
dynamic was significantly different between them correlating with the CF vs. 
non-CF phenotype. In addition, shaking conditions did not affect biofilm 
formation both in CF and non-CF isolates strong biofilm producers (data not 
shown). 
6. Influence of different factors on biofilm formation 
of S. maltophilia clinical isolates 
Biofilm-associated infections substantially affect human health, 
increasing antibiotic resistance of bacteria and making more challenging to 
combat with such infections (Balcázar et al., 2015). However, biofilm formation 
is influenced by different factors (Pompilio et al., 2008; Di Bonaventura et al., 
2007). According to the obtained results among 88 S. maltophilia clinical isolates 
strong biofilm producer represented 7.95% and only nine strains (10.2%) did 
not form biofilm. All strong and moderate biofilm producers as well as five 
selected weak biofilm producers were subject of further analysis regarding 
influence of different factors on biofilm production. Obtained results were 
present as a heatmap (Figure 9). 
In order to access the differences among the isolates abilities to form the 
biofilm, hierarchical clustering was performed. All isolates are divided in four 
differentiated clusters in agreement with hierarchical clustering analysis, 
though isolate clusters slightly overlapped. Clusters represent groups of isolates 
for which similar results in testing different factors on biofilm formation are 
obtained. Interestingly, both groups are present in the CF (black) and non-CF 
(gray) isolates suggesting that origin of strain did not influence the obtained 
results. Decrease or increase of temperature (12°C and 45°C) and changing pH 
of media on 8.5 were the factors which had the highest effect on biofilm 
formation. In addition, importance of the optimal temperature for biofilm 
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formation was shown for the weak biofilm producer also (2483b, 791/15 and 
280H), which formed moderate biofilm on 30°C (Figure 9). Difference was 
demonstrated between CF and non-CF isolates where it was shown that CF 
isolates were more sensitive on changing of temperature, pH and CO2 
concentration. 
 
Figure 9. Heatmap for the biofilm formation under different growth 
conditions of S. maltophilia clinical isolates. Conditions were grouped by 
antibiotic addition (first two), various temperature growth conditions, increased 
CO2 and various environmental pH values. 
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6.1. Effect of trimethoprim-sulfamethoxazole on S. maltophilia 
formed biofilm 
Biofilm as a specific community of bacteria enable them among other 
advantages higher resistance on different antimicrobial agents. In that context, 
the effects of TMP/SMX in two concentrations (25 µg/ml and 50 µg/ml) on S. 
maltophilia formed biofilms was investigated. Both TMP/SMX concentrations 
were found to significantly contribute to the eradication of 24 h old biofilms 
(Figure 9), while 50 µg/ml of TMP/SMX completely eradicated formed biofilm 
in all tested strains, 25 µg/ml of TMP/SMX affects biofilm in a strain-
dependent manner, from complete eradication to no, effect. Interestingly, 
strains more sensitive to other tested factors showed the higher sensitivity on 25 
µg/ml of TMP/SMX. 
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5. DISCUSSION 
Stenotrophomonas maltophilia is an environmental, multidrug resistant 
global opportunistic pathogen. First reports about this bacterium were 
associated with plant growth promoting (PGP) potential. It was isolated from 
plant rhizosphere, which was suggested to be a source of different bacteria 
possessing antibiotic resistance genes (Berg et al., 2005). S. maltophilia can 
acquire and transfer the antibiotic resistance genes to other bacteria species 
through horizontal gene transfer (HGT) (Berg et al, 2017). In addition, this 
bacterium can acquire the genes from Gram-positive bacteria (Alonso et al., 
2000). Ability of S. maltophilia to adapt to the local environment, to interact with 
different bacteria species to receive genetic material from and to transfer genetic 
material to other bacteria makes this opportunistic pathogen one of the major 
challenges in the clinical/medical settings. 
The prevalence of S. maltophilia has increased in hospitals worldwide 
simultaneously with the appearance of a numerous other antibiotic resistant 
bacteria (Brooke JS, 2012; 2014). Serbia was, for decades, among the countries 
where the misuse of antibiotics was high (http://www.who.int/ 
drugresistance/documents/situationanalysis/en/) due to poor and unenforced 
regulation. The years of lax restriction and enforcement could and probably did 
lead to a higher incidence of antibiotic resistant strains. For example, in the 
recent past Serbia, among other Balkan countries, was pointed out as a potential 
endemic region and the second common putative country of origin of isolates 
carrying the New Delhi Metallo-beta-lactamase-1(NDM-1) gene, blaNDM-1 
(Berrazeg et al, 2014; Novovic et al, 2016). Although research of prevalence of S. 
maltophilia in the hospital setting is in the focus of scientific research in the last 
decade, there is no published data about the incidence of S. maltophilia from 
Serbian hospitals. The aim of this study was genotyping, antibiotic resistance 
and determination of virulence factors in the collection of 88 S. maltophilia 
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clinical isolates. In addition, phenotypic characterization of strains isolated from 
patient with cystic fibrosis (CF) and from patients with other diseases (non-CF) 
in order to determine possible existence of CF phenotype. 
For genotyping of S. maltophilia PFGE has proven to be a powerful and 
discriminatory method (Berg et al., 1999) and the same was observed in this 
study. Genomic variability among the 88 analyzed strains was high and 
indicated that there was no cross-transmission among patients. Similar results 
were obtained in previous studies (Valdezate et al., 2004) with rare exception 
(Garciá del Videama et al., 1999). This is not a surprise, since S. maltophilia is an 
environmental bacterium. High genomic diversity of the isolates leads to the 
conclusion that patients were the route of introduction of the analyzed S. 
maltophilia to the hospital setting. This suggestion is also supported by the fact 
that 16 patients from our research had more than one isolate and they were all 
genetically different. Additionally, to the PFGE analysis for identification and 
genotypization of S. maltophilia strains Multilocus sequencing typing (MLST) 
was performed in order to put our results in broader pictures. The results of 
MLST analysis of 11 chosen isolates determined two previously described STs, 
one from Europe and the other from Australia, and six novel STs described for 
the first time in this study (ST114, ST115, ST116, ST117, ST118 and ST119). 
Interestingly, the most dominant STs in Europe (Kaiser et al., 2009) were not 
present among patients from Serbia. The determination of new STs is keeping 
with the high plasticity and capacity of bacterial organisms to adapt to specific 
niches and develop new characteristics. On the other hand, selective pressure 
on these bacteria in the hospital environment could be a reason for the selection 
of certain STs, which have an adaptive advantage in this environment, and this 
could lead to their clonal spread. Accordingly, these results indicate good 
situation in Serbian hospitals since we were not able to detect the most clinically 
prevalent European clinical isolates (Kaiser et al., 2009) and we determined the 
lack of clonal spread. 
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Due to the multiple applications of antibiotics, presence of other 
multidrug-resistant strains, such as P. aeruginosa, Acinetobacter spp. and 
Burkholderia cepacia, in the same ecological niche (hospital settings and CF 
patients) with S. maltophilia is usual. S. maltophilia is intrinsically resistant to 
many antibiotics and easily acquires new resistance phenotypes as well as 
spread it to other bacteria. An increased number of reports from different 
hospitals about S. maltophilia resistant to timethoprim/sulfamethoxazole 
(TMP/SMX) (Toleman et al., 2007; Hu et al., 2016) rose serious concerns, 
especially since TMP/SMX was considered as the main antibiotic for the 
treatment of S. maltophilia. What’s more, for S. maltophilia EUCAST set a 
breakpoint for TMP/SMX, even while the Clinical and Laboratory Standards 
Institute (CLSI) approved standards for levofloxacin, minocycline, 
ticarciline/calvulanate and ceftazidime. On the other hand, results obtained 
with TMP/SMX are the most reproducible, with no relation to the methods in 
susceptibility testing used (Masgala et al., 2010). Our results suggest that all of 
the S. maltophilia analyzed had high susceptibility not only to TMP/SMX but 
also to chloramphenicol, ciprofloxacin, levofloxacin and tetracycline. Then 
again, there is an increasing number of scientific papers on the high rate of S. 
maltophilia resistant to TMP/SMX that point out the need for finding new and 
more effective antibiotics. So far tigecycline and levofloxacin, alone or in 
combination, have shown promising efficancy in the treatment of S. maltophilia 
infections (Farell et al., 2010; Wang et al., 2014). 
The results obtained in our study are even more important since the 
Institute for Mother and Child Health Care "Dr Vukan Čupić" is a paediatric 
tertiary care referral hospital and is the national and regional reference CF 
specialist center for pediatric and adult patients with CF from Serbia, 
Montenegro and Bosnia and Hercegovina. One of the main problems in the 
treatment of CF patients is the emergence of multidrug-resistant strains, so it is 
necessary to establish a pattern of sensitivity to antibiotics in order to apply the 
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appropriate treatment for these patients. Although, results from different 
hospitals, not only in Europe but also worldwide, suggest that S. maltophilia is 
not transmitted from patient to patient and is still susceptible to TMP/SMX 
and/or fluoroquinolones, higher incidence of isolation as well as increased 
percentage of resistant strains pointed the importace of this type of 
research/analysis. Moreover, it is important to get a complete (global-regional) 
epidemiological picture, since from Southeast Europe only data from Greece 
and Hungary are available (Samonis et al., 2012; Juhász et al., 2014). 
Formation of biofilms is a significant problem both in medicine and in 
the food industry. Many antibiotics that are effective against planktonic 
bacterial cells are less effective or completely ineffective against bacteria in 
biofilm (Shanks et al., 2012). Numerous studies have been carried out in recent 
years with the aim of detecting a compound that would inhibit the formation of 
biofilms or lead to the degradation of the already formed biofilm (Saising et al., 
2012, Balaji et al., 2013). Although S. maltophilia is not a highly virulent 
pathogen, its virulence factors, such as adhesion capacity, biofilm formation, 
hydrophobicity, motility and synthesis of extracellular enzymes, contribute to 
the inflammatory process (Di Bonaventura et al., 2010) together with intrisic 
resistance on different antibiotics and aviability for HGT. Dispite its clinical 
relevance, very little is knowen about the pathogenic mechanism of infections. 
A positive correlation between motility, biofilm formation and adhesion to 
mucin was shown in our study. These results are different from those 
previously published (Pompilio et al., 2008), where authors did not find a 
correlation between these three characteristics. They also showed an influence 
of hydrophobicity on adhesion and biofilm formation which was not detected 
in our study. However, another study on CF and non-CF clinical isolates 
pointed to motility as crucial for biofilm development in CF isolates (Pompilio 
et al., 2011). Strains analyzed in this study forming stronger biofilm show high 
motility with no statistically important differences in motility between CF and 
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non-CF isolates. Although, one study suggested that motility was important for 
biofilm formation in CF isolates (Pompilio et al., 2015) in our study lower 
motility in CF pathogens was described. Thus, opposite results point to the 
complexity of the process of biofilm formation especially in the specific 
environment such as lung of CF patients. We also have to consider that most of 
these characteristics are at the bottom line strain specific. Adhesion of S. 
maltophilia to mucin and factors involved in this ability has not been elucidate 
yet. According to our results, clinical isolates of S. maltophilia exhibited the 
ability to adhere to mucin. So far only in one study it was shown that S. 
maltophilia could adhere to mouse tracheal mucus with the help of flagella 
(Zgairt and Chhibber, 2011). 
Surface characteristics, motility of strains, genes involved in biofilm 
formation, and other factors are responsible for abitlty of some strains to form 
biofilm and can be correlated with a higher level of resistance to antibiotics 
(Balcázar et al., 2015). Different factors influenced biofilm formation in S. 
maltophilia, SmeYZ efflux pump, which is not only responsible for antibiotic 
resistance (Lin et al., 2015), level of iron in the media (García et al., 2015) or 
histidin kinase and BfmAK system (Zheng et al., 2016). However, not only 
biofilm formation but also other physiological functions are also regulated with 
above meshed factors such as swimming motility, oxidative stress regulation, 
etc. The molecular basis of biofilm formation in S. maltophila has not been 
characterized yet. In our study we analyzed influence of different factors on 
biofilm fomration. Positive corelation between the simultaneous presence of 
genes spgM and rpfF in one bacterial strain and strong biofilm production in the 
same strain was determined in our study. Interestingly, this correlation was not 
affected by the presence or absence of an rmlA signal. However, the negative 
correlation observed between spgM and rpfF signals could mean that the 
presence of one of these genes, either spgM or rpfF, is required for biofilm 
formation, but the presence of both genes could lead to stronger biofilm 
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production. Still, further examination at the level of spgM and rpfF expression is 
required to support this assumption. 
An interesting observation of this study is the higher motility and 
biofilm-forming potential of non-CF versus CF isolates. Although the loss of 
motility of CF pathogens has already been described as part of their adaptation 
process to the CF environment, the decrease in biofilm formation could not be 
easily explained. Pseudomonas aeruginosa, which is another relevant CF-related 
pathogen, increases biofilm formation in CF lungs, which strengthens its 
resistance to the host’s antimicrobial factors. Pompilio et al. (2015) reported the 
prevalence of P. aeruginosa in mutual biofilm communities formed by P. 
aeruginosa and S. maltophilia in CF lungs. Actually, S. maltophilia stimulates 
biofilm formation by P. aeruginosa. This altruistic behavior of S. maltophilia 
facilitates its survival in these mutual biofilms. Considering this, we can assume 
that only those strains of S. maltophila that are poor biofilm producers survive in 
CF lungs. Otherwise, they would be outcompeted by more prevalent P. 
aeruginosa strains. This might be the reason for the higher incidence of poor 
biofilm-producing strains among CF S. maltophilia isolates in our study. 
Ability of S. maltophilia to survive and adhere within intravenous infuses 
catheters and in dialysis, fluids may contribute to the pathogenesis of 
hemodialysis, intravenous line-related infections, and catheter related 
bacteremia and urinary tract infections. Adhesion is usually followed with the 
biofilm formation. Kinetics of the biofilm formation contributed to level of 
spread of bacteria and its resistance. For selected strains, we determined the 
kinetics of biofilm formation, which showed that non-CF, isolates formed 
biofilm faster than CF isolates. Although, they were all strong biofilm producer 
biofilm formation dynamic was significantly different between them correlating 
with the CF vs. non-CF phenotype. This might be, at least to some extent, 
attributed to the higher motility of non-CF isolates, which was shown in our 
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study also. Kinetics for S. maltophilia attaches and colonizes the polystyrene 
surface suggests that the bacteria could quickly adhere and form biofilm on 
medical instrument and devices that is why the only changing an old medical 
device with a new one could be unproductive, as it may result in adhering the 
planktonic bacteria to the new devices leading to persistent infection. Thus, an 
understanding of biofilm dynamics is important in order to improve better 
control strategies to combat with bacteria in hospital setting. Treatment of an 
infection after biofilm formation is less effective because the biofilm protects 
microorganisms from antimicrobial agents, particularly in 
immunocompromised patients. Once a biofilm has been formed, the bacterial 
cells become extremely robust against different antimicrobial agents. In this 
study, we further investigated the effects of TMP/SMX in two concentrations 
(25 µg/ml and 50 µg/ml) on S. maltophilia formed biofilms. Mechanisms 
providing resistance in biofilm to antimicrobial agents are important to 
understand and determine since they are responsible for inability of the 
antimicrobial agent to penetrate into bacterial biofilm. 
Taking in mind importance of biofilm formation of pathogenic bacteria 
strains in different environments in the present study, we tested the effect of 
environmental factors on biofilm formation of S. maltophilia clinical isolates. For 
the majority of strains optimal temperature for biofilm formation was 37°C. 
Biofilm formation was the most affected with decrease or increase of 
temperature (12°C and 45°C) and changing pH of media on 8.5. The importance 
of the optimal temperature for biofilm formation was shown not only for strong 
and moderate biofilm producers but for the weak biofilm producer also, which 
formed moderate biofilm on 30°C. The temperature was showed to be the most 
relevant factor in biofilm formation of different strains not only in S. maltophilia 
but also in other bacteria species (Di Bonaventura et al., 2007; Di Bonaventura et 
al., 2008; The et al., 2016). In addition, CF isolates were more sensitive on 
changing of temperature, pH and CO2 concentration. Overproduction of thick 
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and sticky mucus in patients with cystic fibrosis forms a specific environment 
that certainly indirectly influences the characteristics of the bacteria that 
colonize it (Cantón and del Campo, 2010). This could be the reason for the slight 
difference in characteristics of CF vs. non-CF isolates, because of adaptation to 
specific environmental conditions. 
Contrary to the aerobic conditions used for in vitro biofilm studies, usual 
situation in the human body in which concentration of CO2 and oxygen 
fluctuates. We found that the maximum levels of S. maltophilia biofilm 
formation were accomplished under aerobic conditions and in CO2 atmosphere. 
These outcomes have significant consequences regarding the pathogenicity of 
individual strains of S. maltophilia in certain infection sites, such as the lung of 
cystic fibrosis patients, which are characterized by either decreased oxygen 
concentration or anaerobic conditions (Worlitzsch et al. 2002; Donaldson and 
Boucher 2003). Such environment could be favorable for the increase of the 
growth of bacterial biofilms and persistent infection. 
In our study, we found that S. maltophilia strains were able to form 
biofilms under both static and dynamic conditions, although in the human host 
biofilms commonly developed under dynamic conditions (i.e. fluid flow 
through catheters, movements of artificial joints, etc.). Regardless of the 
conditions (dynamic vs. static) S. maltophilia strains analyzed in this study were 
biofilm producer. In contrast, in Staphylococcus spp. and Salmonella spp. strains 
the formation of biofilms was remarkably influenced by dynamic conditions 
(Stepanovic et al., 2001; 2004). We revealed that the regulation of biofilm 
production by S. maltophilia is complex and influenced in a strain-specific 
manner by several abiotic factors such as temperature, CO2 concentration, and 
pH. The divergent biofilm responses suggest that S. maltophilia clinical strains 
have the potential to form biofilm but that the capability of individual strains to 
cause disease is also influenced by host factors and environmental conditions at 
the site of infection. 
DISCUSSION 
71 
In summary, this work represents the first study of clonal relatedness 
and antibiotic resistance of S. maltophilia clinical isolates in Serbia. Clonal 
diversity detected in this study indicates low cross-transmission of S. maltophilia 
in the hospital settings. The susceptibility testing gained unremarkable results, 
as strains were universally susceptible to the tested antibiotics. Interestingly, six 
novel S. maltophilia STs were revealed while none of the STs prevalent in 
Europe were identified. Biofilm formation was the prevalent treat in the most of 
the analyzed strains. Complexity of this important virulence factor involves 
mutual influence of strains characteristics and environmental conditions. 
However, we could conclude that for factors tested in this study temperature 
and pH had the strongest effect on biofilm formation. Correlation between 
motility and biofilm formation was confirmed, more motile strain formed 
stronger biofilm. Nevertheless, additional experiments are needed to 
completely evaluate mechanism of action of each factor on biofilm formation of 
this important opportunistic pathogen. A comparison of phenotypic 
characteristics of CF and non-CF isolates suggested that there was a difference 
between the two populations but we could not speak about CF phenotype. This 
study accentuates the need for continuous surveillance for S. maltophilia in 
hospital settings in Serbia and monitoring their evolution towards antibiotic 
resistance. 
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6. CONCLUSIONS
Based on the results presented in this paper, the following conclusions
can be drawn:
1. With the application of the PFGE method and the Phoretix 1D Pro
program, phylogenetic relationships in a collection of 88
Stenotrophomonas maltophilia clinical isolates were determined,
most of the strains do not show significant genetic relatedness
among themselves and the total diversity was grouped into 11
groups.
2. Multilocus sequencing typing (MLST) analysis of 11
representative of each cluster determined six novel ST (ST114,
ST115, ST116, ST117, ST118, ST119) while most common ST in
Europe were not detected.
3. All of the S. maltophilia analyzed were susceptible not only to
trimethoprim/sulfamethoxazole (TMP/SMX) but also to
chloramphenicol, ciprofloxacin, levofloxacin and tetracycline.
4. Only one strain had moderate hydrophobicity, 13590, while all
other strains had low hydrophobicity.
5. Swimming motility was observed in all tested strains, while none
of the tested strains showed swarming or twitching motility.
6. Clinical isolates of S. maltophilia exhibited the ability to adhere to
mucin. There were no differences in mucin-adhesion ability
between CF and non-CF isolates.
7. Strong biofilm was formed by seven strains (7.95%), nine strains
(10.2%) did not form biofilm, moderate biofilm was formed by
37 strains (42.05%), and weak biofilm was formed by 35
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strains (39.8%) with almost equal representation in CF and
non-CF strains.
8. PCR – based analysis revealed that rmlA, rpfF and spgM genes
were present in 86 strains (97.7%), 62 strains (70.4%) and 63
strains (71.6%), respectively. There was no difference in the
presence of the analyzed genes between CF and non-CF
patients. The presence of both rpfF and spgM genes in one
strain was correlated with strong biofilm formation.
9. Non-CF isolates showed higher biofilm forming potential and
motility than CF isolates.
10. Strains forming stronger biofilm show high motility. Motility has
shown positive correlations with both biofilm formation and
the mucin-adhesion ability of the strains.
11. Kinetics of biofilm formation of strong biofilm producers showed
that non-CF isolates formed biofilm faster than CF isolates.
12. Decrease or increase of temperature (12°C and 45°C) and
changing pH of media on 8.5 were the factors which had the
highest effect on biofilm formation.
13. TMP/SMX in 50 µg/ml concentration completely eradicated 24 h
old formed biofilm in all tested strains, while 25 µg/ml of
TMP/SMX affects biofilm in a strain-dependent manner.
14. A comparison of phenotypic characteristics of CF and non-CF
isolates suggested that there was a difference between the two
populations but we could not speak about CF phenotype.
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